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Abstract 
     Cystic fibrosis (CF) is a genetic disorder caused by mutations in the gene encoding for 
the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. Currently, 
more than 4,100 Canadians have CF. The major cause of CF morbidity and mortality is airway 
disease, for which there is no cure. 
     The events leading from CFTR gene mutation to CF airway disease are not fully 
understood, and there is controversy regarding the primary defect responsible for CF airway 
disease pathogenesis. Newborn CFTRΔF508/ΔF508 and CFTR-/- swine show no sign of infection 
and inflammation in the lung but suffer from defective bacteria eradication caused by abnormal 
innate immune system. The cornerstone of the airway’s innate immune defense is mucociliary 
clearance, which relies on the normal regulation of airway surface liquid (ASL), which covers 
the airway epithelium. It has been hypothesized that abnormal ASL is the primary defect that 
leads to the failure of the airway innate immune defense in CF. Evidence show that the airway 
submucosal gland functions abnormally in both CF patients and in animal models of CF. This 
is not surprising since airway submucosal glands normally express CFTR. However, the 
function of the gland in health and disease is not fully understood. The response of airway 
submucosal gland to inhaled bacteria has never been tested and its ion transport properties have 
not been fully described.      
     Our objective is to investigate the effect of inhaled bacteria on airway submucosal gland 
secretion, and to study and compare the function of different segments of airway submucosal 
gland in wild-type and CF airway. Knowledge generated by this thesis would help better 
understand CF airway pathophysiology and may contribute to improving treatment methods. 
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Chapter 1 
Introduction and Literature Review 
 
1.1 Cystic fibrosis 
     Cystic fibrosis (CF) is the most common fatal genetic disease affecting young Canadians. 
CF is an autosomal recessive condition caused by mutations in the gene encoding the cystic 
fibrosis transmembrane conductance regulator (CFTR) anion channel. According to Cystic 
Fibrosis Canada, there are over 4,100 CF patients in Canada. One in every 3,600 newborn 
Canadian has CF, which means that about one baby every week is diagnosed with CF in Canada. 
And approximately one in every 25 Canadians carries a defective version of the gene 
responsible for CF (The Canadian Cystic Fibrosis Registry 2014 Report). Although the 
estimated median age of survival for CF patients in Canada is more than 50 years old, which 
is among the highest in the world, CF still remains a disease without a cure, and current 
treatments are inadequate. 
     CF was first recognized in the 1930s by Dorothy Hansine Andersen (Andersen, 1938), 
who described the medical condition ‘cystic fibrosis of the pancreas’, where the name of cystic 
fibrosis comes from. At that time, the estimated median age of survival was 6 months, and the 
poor growth resulting from digest system symptoms was the focus of CF treatments (Davis, 
2005).  
     In 1989 researchers at The Hospital of Sick Children, in Toronto, discovered the mutated 
gene that causes CF, in the human chromosome 7 (Kerem et al., 1989; Riordan et al., 1989; 
Rommens et al., 1989). It was the CFTR gene, which encodes for an anion channel localized 
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on the membranes of epithelial cells and allows the movement of chloride and/or bicarbonate 
ions across the epithelial layer (Boucher, 1994). 
The protein product of the CFTR gene has 1,480 amino acids and contains five different 
domains, as shown in Fig. 1.1. The CFTR protein consists of two transmembrane membrane-
spanning domains (MSD1 and MSD2), which help form the central channel; two nucleotide-
binding domains (NBD1 and NBD2) that can regulate the channel by ATP hydrolysis; and a 
regulatory domain (R), where phosphorylation of sites on R domain leads to the activation the 
CFTR channel (Sheppard and Welsh, 1999). As a member of the ATP-binding cassette 
transporter protein family, CFTR works as a cAMP-activated ATP-gated anion channel that 
transfers chloride and/or bicarbonate across the membrane along an electrochemical gradient 
(Wine, 2001). Both a phosphorylated R domain and ATP-hydrolyzed NBDs are required to 
open or close the CFTR channel that allows transmembrane flow of anions (Sheppard and 
Welsh, 1999). 
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Fig. 1.1 Model showing proposed domain structure of cystic fibrosis transmembrane conductance regulator 
(CFTR). MSD, membrane-spanning domain; NBD, nucleotide-binding domain; R, regulatory domain; PKA, 
cAMP-dependent protein kinase (adapted from Sheppard and Welsh, 1999). 
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1.2 CFTR mutations  
     Over 2,000 mutations have been identified in the CFTR gene (Cutting, 2015; Castellani 
and Assael, 2017), which have been classified into 6 different classes based on the mechanism 
of dysfunction. Class 1 nonsense mutations cause no CFTR protein to be present due to 
premature stop codons. Class 2 mutations result in misfolded or improperly processed CFTR 
protein, and the unstable CFTR protein is degraded rapidly. Class 3 gating mutations lead to 
full-length CFTR protein to be present on the cell membrane, but the channel has difficulty to 
open. Class 4 mutations cause the CFTR channel on the membrane to have reduced 
conductivity. Class 5 mutations lead to a reduction in the amount of functional CFTR protein 
due to splicing defects or inefficient trafficking. Class 6 mutations result in functional CFTR 
protein to be unstable on the cell membrane (Egan, 2016; Castellani and Assael, 2017). The 
most common CFTR mutation is a class 2 mutation caused by the deletion of 3 base pairs, 
resulting in a loss of the amino acid phenylalanine at the 508th position of the protein. This 
mutated protein is referred as ΔF508, and is found in about 70% of the patients. This mutation 
leads to abnormal folding of CFTR proteins and quick degradation of CFTR by the quality 
control mechanisms in the endoplasmic reticulum, thus there is low expression of CFTR on the 
cell membrane (Kerem et al., 1989; Cutting, 2016).  
     
1.3 CF airway disease  
     CFTR is expressed in the epithelial cells of many organs, such as the lung, liver, pancreas, 
digestive tract, reproductive tract, and sweat glands (Sheppard and Welsh, 1999). Among these, 
the digestive and respiratory systems are most affected by CF disease. The gastrointestinal 
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symptoms cause problems digesting and absorbing nutrients, thus causing malnutrition and 
poor growth (O’Sullivan and Freedman, 2009). Digestive system abnormalities were the focus 
of CF treatment therapy in the early era of CF research. With the development of modern diets 
and pancreatic enzyme replacement therapies, the CF digestive symptoms have been 
significantly improved and most CF patients can manage gastrointestinal symptoms (Haack et 
al., 2013). Currently, most of the morbidity and mortality for CF patients arises from airway 
diseases (The Canadian Cystic Fibrosis Registry. 2009 Annual Report). Although the median 
age of CF patients in Canada has been significantly advanced in the last 25 years, from 13 to 
22 years of age (The Canadian Cystic Fibrosis Registry. 2009 Annual Report), CF continues to 
be a lethal disease since CF patients suffer non-reversible lung damage.  
     The hallmarks of CF lung disease include chronic bacterial airway infection (frequently 
with Pseudomonas aeruginosa, Staphylococcus aureus, and Haemophilus influenzae), 
prominent neutrophilic inflammation, and mucus accumulation in airways (Stoltz et al., 2010; 
Goetz and Singh, 2016). Chronic infection and inflammation results in airway remodeling and 
airway blockage in CF patients, which finally leads to chronic bronchoectasis. Bronchiectasis 
in CF patients leads to reduced lung function (reduced forced expiratory flow (FEF) and forced 
expiatory volume in 1 second (FEV1)), pulmonary exacerbations, and in some cases respiratory 
failure (Castellani and Assael, 2017).  
     Many therapies have been used to treat CF, including antibiotics to prevent infection 
(Conway et al., 2014), anti-inflammatory drugs (O’Sullivan and Freedman, 2009; Castellani 
and Assael, 2017), airway hydrators (hypertonic saline) (Donaldson et al., 2006; Elkins et al., 
2006; Tildy and Rogers, 2015; Reeves et al., 2015), mechanical airway clearance therapy (chest 
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percussion and drainage) (Flume et al., 2009), and lung transplantation (Flume and Van 
Devanter, 2012; Castellani and Assael, 2017). Most of the current treatments focus on 
improving the symptoms of CF airway disease. Thus, there is great interest in studying the 
relation between CFTR mutation and the pathogenic event that triggers the onset of CF lung 
disease. 
 
1.4 CF airway disease pathogenesis  
     Although chronic infection and inflammation are hallmarks of CF lung disease, recent 
data show that lungs of newborn patients and CF animal models are mostly healthy (Stoltz et 
al., 2010; Ostedgaard et al., 2011). Thus, the central question is how a ‘healthy’ looking CF 
lung at birth, progresses to the heavily damaged respiratory system seen in later years. Several 
hypotheses have been generated to explain the onset of CF airway disease. These include 
abnormal adherence of bacteria to airway epithelia (Pier et al., 1997), pro-inflammatory 
tendency in the CF airway (Machen, 2006), and the failure of the innate immune defence 
system against bacteria due to reduced airway surface liquid (ASL) volume caused by increased 
liquid reabsorption (Boucher, 1994) and/or decreased liquid secretion (Joo et al., 2006), and 
changes in the composition of ASL (Guggino, 1999).  
     Over that last few years, especially since the development of swine CF models, research 
suggests that the pathogenic event that triggers the onset of CF airway disease is the failure of 
the innate immune defence system against bacteria in the airways (Stoltz et al., 2015). 
 
1.4.1 Innate immune defence in the airway 
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      A normal person inhales ~8,000 liters of air per day which may contain somewhere 
between 5,000 and 14,000 pathogens and irritants. Normal airways are protected from these 
inhaled particles by a complex immune defense system (Wine, 2007). The cornerstone of this 
airway defence consists of trapping particles in ASL and then clearing them out of the airway 
through ciliary flow, i.e. mucociliary clearance.  
     The ASL is an aqueous fluid containing ions, mucins, and antimicrobial factors including 
lactoferrin, lysozyme, and surfactant proteins. When inhaled pathogens land on the airway, they 
are trapped by the ASL layer. Antimicrobial factors in ASL kill and/or inactive inhaled 
microbes. Finally, pathogens are removed from the airway by efficient mucociliary clearance, 
which requires sufficient ASL height to maximize ciliary movement (Wine, 2007; Verkman et 
al., 2003).  
     This innate immune response seems to fail in the CF airway. There is increasing evidence 
showing that abnormal ASL in CF patients results in the loss of airway defence function 
(Verkman et al., 2003). In CF airways, the ASL composition and secretion is abnormal and thus 
fails to kill inhaled pathogens, leading to chronic infection and inflammation that may 
eventually cause respiratory failure (Stoltz et al., 2015; Williams and Davies, 2012). 
     Two hypotheses have been proposed to explain how CFTR mutation causes the abnormal 
airway ASL in CF patients: 1) increased liquid absorption causing ASL dehydration (Boucher, 
2007) and/or 2) abnormal ASL secretion by airway submucosal glands (Wine and Joo, 2004).  
     The first hypothesis suggests that the loss of CFTR causes airway surface epithelia to 
hyper-absorb liquid from the lumen, i.e. drying the airway. Evidence indicates that CFTR 
normally inhibits the activity of the epithelial Na+ channel (ENaC). In CF cells, the loss of 
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CFTR results in ENaC hyper-activity, which leads to excessive liquid absorption by airway 
epithelial cells (Boucher, 2007). This leads to dehydration of the CF airway ASL, and the 
collapse of mucociliary clearance. However, this hypothesis has been challenged recently by 
Welsh and colleagues who show that the loss of the CFTR channel in the CF pig and CF patients 
does not increase sodium absorption in the airway (Chen et al., 2010; Itano et al., 2011). In 
addition, accumulating evidence suggests that the second hypothesis may be correct, where the 
failure to eradicate bacteria effectively in CF airways may be the result of abnormal ASL 
secretion by submucosal glands.  
 
1.5 Airway submucosal glands 
     The airway submucosal glands are located beneath the airway surface and seem to play 
an important role in CF pathobiology (Wine and Joo, 2004; Engelhardt et al., 1992). 
Submucosal glands secrete about 95% of the ASL in the upper airway (i.e. trachea and bronchi) 
(Joo et al., 2006; Wine and Joo, 2004). The glandular secretion consists 90-98% of water, 
different types of ions, gel-forming mucins, and antimicrobial factors that are essential for the 
airway defence against inhaled pathogen (Widdicombe and Wine, 2015).  
     However, the secretion, composition, and rheological properties of the ASL are abnormal 
in CF airway. Gland secretion collected from CF patients and CF swine was more viscous than 
that from healthy controls due to elevated mucin concentration in CF gland secretion and the 
lack of CFTR-dependent bicarbonate secretion (Widdicombe and Wine, 2015; Jayaraman et al., 
2001; Hoegger et al., 2014). Moreover, abnormal pH and composition of the ASL have been 
proposed to result in reduced bacterial killing in CF airway, which facilitates infection of the 
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airways (Pezzulo et al., 2012; Verkman et al., 2003). And stimulation with secretagogues that 
normally trigger ASL secretion fails to stimulate ASL production in CF patients and in mice, 
rat, ferret, and swine CF models (Tarran et al., 2006; Joo et al., 2006; Engelhardt et al., 1992; 
Wine and Joo, 2004; Lee and Foskett, 2010; Ianowski et al., 2007; Joo et al., 2010; Choi et al., 
2010). Thus, it has been proposed that failure to secrete ASL in response to inhalation of 
pathogens in CF may facilitate bacterial colonization by reducing the amounts of gland-derived 
antimicrobial factors in the airway (Joo et al., 2004).  
 
1.6 Regulation of gland secretion 
     Since the liquid secretion from airway submucosal gland is very important for airway 
defence (Verkman et al., 2003; Haq et al., 2016), its secretion needs to be carefully regulated. 
The airways submucosal gland secretion is regulated by the central nervous system, and 
through airway local signals, which produce two separate responses: an emergency response 
and a ‘housekeeping’ response.  
     The emergency response of the gland is triggered by situations that are immediately 
deleterious to the individual, such as inhalation of water or toxic substances, and it is controlled 
by the central nervous system via the vagus nerve. When activated, the emergency response 
triggers large volumes of ASL secretion, and it is normally accompanied by airway constriction 
and cough. This pathway of stimulation of gland secretion is mediated by the release of 
acetylcholine (ACh), increases in intracellular Ca2+ concentration, and activation of calcium-
activated chloride channels (CaCCs). This emergency response remains in CF patients, since 
it functions independently of CFTR (Choi et. al., 2009; Ianowski et. al., 2007; Joo et. al, 2010; 
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Joo et. al., 2002).  
     The ‘housekeeping’ function of airway submucosal glands has been proposed play a 
major role in protecting the airways from mundane, smaller insults, such as inhalation of small 
numbers of noxious particles during daily activities. It ensures sufficient ASL volume in the 
airway to allow for an efficient mucocilicary clearance process, which is required to keep the 
airways clean and uninfected (Wine, 2007; Widdicombe and Wine, 2015). However, little is 
known about the ‘housekeeping’ response of airway submucosal gland, specially about the 
response of submucosal gland secretion against inhaled pathogens. It remains unknown for 
example how airway submucosal glands respond to inhaled bacteria. Furthermore, it is also 
unclear why and how airway submucosal glands produce abnormal ASL in CF. 
 
1.7 General hypothesis 
     The general hypothesis of this thesis is that inhalation of bacteria triggers airway 
submucosal glands to secrete ASL, which contains antimicrobial compounds and mucin 
required to help clear the insult. In CF airway this response fails and leads to the failure of 
pathogen eradication.  
 
1.8 Thesis objectives 
     The objectives of my dissertation are:  
     1) to study the effect of inhaled bacteria, especially P. aeruginosa, on ASL secretion in 
the trachea of swine, and to test the role of CFTR in the process (Chapter 2), 
     2) to study the effect of inhaled bacteria on ASL secretion in vivo using CFTR-/- swine, 
and to study the possible mechanism of the proposed basal spontaneous ASL (Chapter 3), 
     3) to test the contribution of the nervous system and airway epithelia secretion to 
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hypertonic saline (HTS) nebulization-stimulated ASL production (Chapter 4), 
     4) to investigate the ion transport properties of different segments of airway submucosal 
gland in wild-type and CFTR-/- tissue (Chapter 5), and  
     5) to develop a new imaging strategy to study the pathogenesis of CF small airway 
disease (Appendix A). 
 
1.9 Summary of manuscripts 
Pseudomonas aeruginosa triggers CFTR-mediated airway surface liquid secretion in 
swine trachea 
     Significance: This study provides the first demonstration that inhalation of bacteria 
triggers CFTR-dependent ASL secretion. We suggest that this response to inhaled pathogens is 
an important but previously unknown part of the innate immune response that would be missing 
in CF patients, resulting in reduced bacterial killing and facilitating infection. 
     Contribution: I was the primary investigator of this study. I was involved in designing 
the research, performing the research, analyzing data, and writing the paper. 
 
Cystic fibrosis swine fail to secrete airway surface liquid in response to inhalation of 
pathogens 
     Significance: The study represents the first study of ASL secretion mechanisms in a live 
animal. We show that a bacteria-triggered and a basal spontaneous ASL secretion in wild-type 
but not in pig models of CF, suggesting an impaired response to pathogens contribute to 
infection.  
     Contribution: I was the primary investigator of this study. I was involved in developing 
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the experimental techniques, conducting the experiments, analyzing data, interpreting data, and 
contributing to writing the manuscript.
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Chapter 2 
Pseudomonas aeruginosa triggers CFTR-mediated airway surface liquid secretion in 
swine trachea 
     Citation: Luan X, et al. (2014) Pseudomonas aeruginosa triggers CFTR-mediated airway 
surface liquid secretion in swine trachea. Proc Natl Acad Sci U S A 111(35):12930-12935. 
     Disclaimer: Manuscript has been reformatted for consistency with the dissertation, 
including some rearrangement. References have been moved to the end of the dissertation as 
per CGSR requirements. No other content has been changed. 
 
2.1 Abstract 
Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in 
the gene encoding for the anion channel CFTR. Several organs are affected in CF, but most of 
the morbidity and mortality comes from lung disease. Recent data show that the first 
consequence of CFTR mutation is the failure to eradicate bacteria prior to the development of 
inflammation and airway remodeling. Bacterial clearance depends on a layer of airway surface 
liquid (ASL) consisting of both a mucus layer that traps, kills and inactivates bacteria, and also 
a periciliary liquid layer that keeps the mucus at an optimum distance from the underlying 
epithelia to maximize ciliary motility and clearance of bacteria. The airways in CF patients and 
animal models of CF have abnormal ASL secretion and reduced antimicrobial properties. Thus, 
it has been proposed that abnormal ASL secretion in response to bacteria may facilitate the 
development of the infection and inflammation that characterize CF airway disease. However, 
whether the inhalation of bacteria triggers ASL secretion and the role of CFTR has never been 
tested. We developed a synchrotron-based imaging technique to visualize the ASL layer and 
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measure the effect of bacteria on ASL secretion. We show that the introduction of Pseudomonas 
aeruginosa and other bacteria into the lumen of intact isolated swine tracheas triggers CFTR-
dependent ASL secretion by the submucosal glands. This response requires expression of the 
bacterial protein flagellin. In patients with CF, the inhalation of bacteria would fail to trigger 
ASL secretion, leading to infection and inflammation.  
 
2.2 Introduction 
     The human airway is normally protected from injury caused by microbial colonization 
and viral infection by a complex immune defence system. The cornerstone of airway defence 
is mucociliary clearance. Particles, including bacteria, are captured in mucus and removed by 
an efficient mucociliary clearance mechanism. Airway host defence is compromised in people 
with cystic fibrosis (CF). As a result, their lungs suffer from chronic bacterial infections, 
frequently with Pseudomonas aeruginosa, and inflammation that may eventually cause lung 
tissue damage and respiratory failure (Pilewski and Frizzell, 1999; Sheppard and Welsh, 1999). 
The events leading from Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene 
mutation to airway disease are not fully understood, but accumulating evidence suggests that 
CF airway disease results from abnormal microbial clearance (Pezzulo et al., 2012; Stoltz et 
al., 2010). 
     Although chronic inflammation is a major part of CF lung disease, recent data show that 
the first consequence of CFTR mutation is an impaired ability to eradicate bacteria. Lungs from 
animal models of CF (F508del and CFTR-/- pigs) (Rogers et al., 2008; Sun et al., 2010) fail to 
eradicate bacteria as effectively as wild-type littermates before the development of 
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inflammation (Pezzulo et al., 2012; Stoltz et al., 2010). These results suggest that impaired 
bacterial elimination is the pathogenic event that initiates a cascade of inflammation and 
pathology in CF lungs (Stoltz et al., 2010).  
     The failure to clear bacteria likely results from abnormal airway surface liquid (ASL) 
secretion and properties (Sun et al., 2010; Ianowski et al., 2007; Joo et al., 2010; Joo et al., 
2002; Wine, 2007). The ASL consists of a layer of mucus that traps inhaled particles, and a 
periciliary liquid layer that keeps the mucus at an optimum distance from the underlying 
epithelia to maximize ciliary mobility (Wine, 2007; Knowles and Boucher, 2002). The mucus 
layer is a sophisticated mixture of water, salts, gel-forming mucins and antimicrobial 
compounds that helps inactivate, kill, and trap pathogens and facilitates mucociliary clearance 
(Wine, 2007; Knowles and Boucher, 2002). In CF airways, both the bacteria-killing properties 
and the secretion of the ASL are abnormal (Pezzulo et al., 2012, Joo et al., 2002). The airway 
liquid produced by CFTR-/- swine has lower bactericidal properties compared to wild type 
littermates due to abnormal pH (Pezzulo et al., 2012; Stoltz et al., 2010). In addition, human 
CF airways, 1-day old CF piglets, newborn CFTR-/- ferrets and CFTR-/- mice fail to respond to 
stimulatory signals that normally elicit strong ASL secretion (Sun et al., 2010; Ianowski et al., 
2007; Joo et al., 2010; Joo et al., 2002). Thus, it has been proposed that abnormal secretion of 
fluid and mucin in response to bacterial infection may contribute to CF lung disease 
pathogenesis (Ianowski et al., 2007; Joo et al., 2010; Joo et al., 2002; Wine, 2007; Martens et 
al., 2011; Baniak et al., 2012; Reid, 1960; Ianowski et al., 2008). However, the central question 
of whether bacteria trigger ASL secretion in the airways and the role of CFTR in such a process 
has never been tested due to the lack of a suitable experimental technique.  
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     We developed a novel synchrotron-based method to measure the height of the airway 
surface liquid (ASL) layer covering the epithelium of intact, isolated swine trachea. We show 
that the introduction of P. aeruginosa into the lumen of intact isolated swine tracheas triggers 
CFTR-dependent ASL secretion by the submucosal glands. This is a local response that only 
affects the glands in close proximity to the bacteria and requires expression of the bacterial 
protein flagellin. We also show that Staphylococcus aureus and Haemophilus influenzae also 
trigger CFTR-dependent ASL secretion, indicating that this response is not unique to P. 
aeruginosa. In patients with CF, the inhalation of bacteria would fail to trigger ASL secretion 
by submucosal glands facilitating infection and inflammation.  
 
2.3 Materials and Methods 
Animals 
     Tracheas were obtained from juvenile female and male pigs weighing 15-25 kg from the 
Prairie Swine Centre, University of Saskatchewan. The tracheas were dissected within 15-30 
minutes of euthanasia, clamped at both ends in order to prevent fluid from entering the trachea 
and placed in ice-cold Krebs-Ringer solution (mM): 115 NaCl, 2.4 K2HPO4, 0.4 KH2PO4, 1.2 
CaCl2, 1.2 MgCl2, 25 NaHCO3, 10 glucose (pH=7.4) equilibrated with 95% O2, 5% CO2 until 
used. 
 
X-ray imaging  
     Experiments were performed on the BioMedical Imaging and Therapy-Bend Magnet 
(BMIT-BM) beamline 05B1-1 at the Canadian Light Source (CLS). All the experiments were 
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approved by the CLS and the Animal Ethics Committee at the University of Saskatchewan. 
     The experimental hutch was located 25.5 meters away from the storage ring. Phase 
contrast imaging (PCI) was performed using monochromatic 20 keV (λ=0.062 nm) x-rays, 
selected using a standard double-crystal monochromator. Iodine K-edge subtraction imaging 
was performed using monochromatic 33.20 keV and 33.35 keV. Barium K-edge subtraction 
imaging was performed using monochromatic 37.50 keV and 37.65 keV. The beam size was 
100.0 mm (wide) x 8.0 mm (vertical). The distance between sample and detector was 65 cm. 
Images were captured using a high resolution x-ray converter (AA-60, Hamamatsu Photonics) 
with a charge-coupled device (CCD) detector (C9300-124, Hamamatsu Photonics). The 
converter used a 10 μm-thick scintillator (Gd2O2S:Tb) to convert x-rays to visible light, which 
was then directed to the CCD. The pixel size of the image was 8.75 x 8.75 μm. The exposure 
time ranged from 600 to 900 ms.  
     The trachea preparation was placed in a custom-built chamber. The tissue was immersed 
in Krebs solution plus 1 μM indomethacin at 35ºC and equilibrated with 95% O2 and 5% CO2. 
The lumen of the trachea preparation remained free of solution and sealed, but was accessible 
to the researchers to introduce the agarose beads. Agarose beads, ~200 to 800 μm diameter, 
were blotted dry and placed in the lumen of the preparation using a cotton swab. Before 
measuring ASL height each bead was placed at the point where the air-ASL interface is parallel 
to the x-rays reaching the sample, i.e. the top or bottom of the preparation (Fig. 2.1a), using a 
computerized experimental stage. We made two ASL height measurements, one 5 min after 
instillation of the beads and another after 35 min after instillation. For our experiments, the 
measurements made at 5 min should be interpreted as the initial state of the airway, i.e. before 
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exposure to bacteria. We labeled the first time point as 5 min because there was a 5 min delay 
between instillation of the beads and acquisition of the first image.  
 
Preparation of agarose beads  
     We used agarose beads as devices to measure the height of the ASL (Fig. 2.S1). The 
height of the ASL layer was measured as the distance between the air-liquid interface and the 
edge of the agarose bead touching the surface epithelia (Fig. 2.S1).  
     Agarose beads were made in sterile conditions with 4% agarose in PBS as described 
elsewhere (Cash et al., 1979; Chmiel et al., 2002). In order to make the beads visible by x-ray 
we added BaSO4 or CuI (1 M) as contrast agents. These salts were chosen because they are not 
soluble in water and, thus, did not contribute to the osmotic pressure of the bead. The 
osmolarity was 278 ± 0.1, 276 ± 0 and 279 ± 0 mOsm for PBS, 1M BaSO4 and 1M CuI, 
respectively (n=6 per group).  
 In addition, the beads were used as a delivery system for bacteria to the airway. 
Bacteria-laden agarose beads were made by adding 10% of bacteria stock solution to sterile 
PBS. P. aeruginosa stock solution was made with a clinical isolate P. aeruginosa generously 
provided by Dr. Gordon at the University of Saskatchewan (NH57388) (Hoffmann et al., 2005). 
An aliquot of P. aeruginosa NH57388 was inoculated in 80 ml of TSB in a 2 l Erlenmeyer 
flask and incubated for 28 h at 37ºC shaking at 170 rpm. The culture was then heat killed 
(incubated at 80ºC for 30 min) and stored at -20ºC until use. Clinical isolates of Hemophilus 
influenzae and Staphylococcus aureus (generously provided by Dr. Blondeau at the Royal 
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University Hospital, Saskatoon, Saskatchewan, Canada) and P. aeruginosa strains PAK and 
PAKΔfliC strains were prepared in an identical manner.  
 
Secretion assay 
     A small piece of trachea was cut along the trachealis muscle and the airway submucosa, 
containing the glands, was dissected from the cartilage as described previously (Joo et al., 
2001). This submucosa preparation was placed in a custom built chamber with the serosal side 
bathed in Krebs solution containing 1 μM indomethacin. The mucosal side was cleaned, dried 
with a stream of air and coated with ~5 μl mineral oil. Mucus secreted by the submucosal 
glands formed a spherical droplet under the mineral oil. The preparation was maintained at 
37ºC and equilibrated with warm and humidified 95% O2 5% CO2 gas (TC-102, Medical 
Systems Corp., Greenvale, NY, US). Flagellin (10 ng/ml) was added to the serosal side, and 
the droplets of ASL secreted by the glands were imaged every 120s and stored for offline 
analysis using ImageJ 1.43u (NIH). The volumes of the secreted droplets were calculated 
assuming a spherical shape (V = 4/3πr3) (Joo et al., 2001). The secretion rate was calculated by 
fitting the volume versus time plots with straight lines using linear regression, and the slopes 
were taken as the secretion rates using at least four points (Joo et al., 2002). 
     We used a modified secretion assay to test whether bacteria stimulate the release of 
paracrine signals that may trigger ASL secretion. A piece of trachea was prepared as described 
above except that the mucosal side was not cleaned or dried. Instead, we incubated the mucosal 
side of the preparation with ~5 µl of PBS or P. aeruginosa stock solution. After 35 min we 
collected the Krebs solution bathing the serosal side of the preparation and tested it using the 
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secretion assay as described above.  
 
Surgical removal of the submucosal glands 
     The trachea preparation was clamped at both ends so that the lumen was filled with air. 
The cartilage was removed with the aid of a scalpel and a blunt-ended elevator. Once the 
cartilage was removed the submucosal glands and other tissue in the submucosa was dissected 
out by "shaving" with a breakable scalpel blade (Fine Science Tools, Vancouver, Canada). The 
procedure took ~30 min. We tested the effectiveness of our procedure by performing it in a set 
of tracheas and then counting the number of viable glands in a secretion assays. We compared 
the number of viable glands in tracheas with glands removed with control tracheas that were 
subjected to the same procedure but without removing the glands. The data showed that our 
procedure allowed us to remove 90% of glands from the trachea. 
     The surface epithelium was not affected by the dissection procedure. During gland 
dissection the trachea remains filled with air and clamped on both ends. The dissection tools 
never touched the surface epithelia. We tested the condition of the surface epithelium after 
dissection of submucosal glands by measuring short circuit currents in an Ussing chamber. The 
experiments showed that preparations subjected to the dissection procedure (removal of the 
cartilage) but with submucosal glands intact had a short circuit current (Isc) of 24 µA/cm2. 
Similarly, preparations where we dissected the glands out had a Isc of 20 µA/cm2. Addition of 
amiloride (10-4 M apical side) reduced the Isc to 12 and 9 µA/cm2 for preparations with and 
without glands, respectively. Stimulation with forskolin (10-5 M apical side) stimulated Isc to 
20 and 17 µA/cm2 for preparations with and without glands, respectively. These results showed 
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that the surface epithelium was not affected by the dissection procedure.  
 
RT-PCR  
     Total RNA was extracted from 10-20 mg of tissue (surface epithelia, submucosal glands, 
heart and lung) using RNAqueous kit (Ambion). Airway surface epithelium was dissected from 
swine trachea and was free of submucosal glands. Submucosal glands were individually 
dissected and cleaned of connective tissue. RNA was reverse transcribed using Platinum II Taq 
DNA Polymerase  (Invitrogen) using the following gene specific primers: TLR5 (AB208697) 
5’-GGCCATAGTCAGATCGCATTCTTGC-3’and 5’-
GATCAATGGCCTTCAAGGAATTCAG-3’, amplicon size 223 bp (Shinkai et al., 2006),   
IL-1R1 (XM005662366) 5'- ACGGGTCCACCTCTAACTCA-3' and 5'- 
CAGCAATGCTTTCCCCAACG-3', amplicon size 123 bp and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; AF017079) 5’- GATGGTGAAGGTCGGAGTGAACGG-3’and 5’-
CCTGGAAGATGGTGATGGGATTTCC-3’, amplicon size 231 bp (Ostedgaard et al., 2011). 
Annealing temperature was 58°C. Negative controls were performed by omitting the MMLV 
reverse transcriptase enzyme (Ambion) in the RT reaction or omitting the input cDNA in the 
PCR reaction. The positive control was lung parenchyma for TLR5 (Ostedgaard et al, 2011) 
and heart muscle for IL-1R1 (Zitta et al., 2010). PCR was held at 94°C for 2 min and cycled 
40 times. Each cycle consisted of 94°C for 30 s (denaturation), 58°C for 30 s (annealing), and 
72°C for 1 min (extension). This was followed by a 10 min final extension at 72°C. PCR 
products were visualized on an ethidium bromide-stained 2% agarose gel under ultraviolet 
illumination. The product of the PCR was extracted from the gel and sequenced (Pure Link gel 
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extraction kit, Invitrogen). The amplified product matched the DNA sequence for TLR5 and 
IL-1R1 from Sus scrofa Blast database. 
 
Confocal Immunofluorescence  
     Freshly-dissected submucosal glands from pig trachea were fixed in 4% 
paraformaldehyde overnight at 4° C. After washing in PBS (3 × 5 min) submucosal glands 
were incubated with antibodies for confocal immunofluorescence. The following antibodies 
were applied sequentially: 1) polyclonal rabbit antibody anti-human (pig reactive) lysozyme, 
(Lyz; 12 mg/L; Abcam, Cambridge, MA, USA) applied overnight at 4 °C; 2) FITC-conjugated 
secondary antibody against rabbit (1:100; Abcam) applied for 1 hr at RT; 3) polyclonal rabbit 
anti-human (pig reactive) interleukin 1 receptor type 1 (IL-1R1; 1:100; Santa Cruz 
Biotechnology Inc., Dallas, TX, USA) applied for 1hr at 37 °C; 4) Texas Red-conjugated 
secondary antibody against rabbit (1:100; Abcam) applied for 1hr at RT. Antibodies were 
diluted in PBS containing 1 % BSA (Sigma) and 0.5 % Triton X-100 (Sigma). After each 
incubation, the samples were washed in PBS (3 × 5 min). Samples were covered with the anti-
photobleaching mounting medium Vectashield with DAPI (Vector Laboratories, Burlingame, 
CA, USA) and viewed with a confocal microscope (LSM 510 Confor 2, Carl Zeiss, 
Oberkochen, Germany) equipped with diode (405nm), argon (488nm), and helium/neon (543 
nm) lasers. Tissue was scanned in optical sections using LSM510/ConfoCor2 (Version 3.2 
SP2) software (Zeiss). In control experiments pre-incubation with either blocking peptide or 
omission of the primary antibody resulted in complete abolition of staining. In control 
experiments blocking peptide for IL-1R1 (Santa Cruz Inc.) was pre-incubated with primary 
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antibody (5 µg peptide/1 µg antibody) overnight at 4o C before application. Image processing 
was performed using Adobe Photoshop CS5 software. 
 
Reagents 
     CFTRinh172, IL-1β, and flagellin from Salmonella typhimurium were obtained from 
Cedarlane Labs (Burlington, ON, CA). A stock solution of CFTRinh172 was dissolved in 
DMSO. The final concentration of DMSO was less than 0.1%. The solution of IL-1β and 
flagellin were dissolved directly in Krebs solution.  
 
Statistics 
     Data sets displaying normal distribution are presented as means ± SEM while other data 
sets are presented as median and scatter plot. The data were tested for normality using 
Kolmogorov-Smirnov test and the variances were tested using F test for unequal variances. 
Those data sets that showed normal distribution and variances were not different were analyzed 
using Student's t-test or ANOVA as appropriate. Other data sets were analyzed using the non-
parametric paired test, Wilcoxon signed-rank test. Analysis was performed using GraphPad 
Prism 5 (GraphPad Software Inc., San Diego, CA, US). All statistical analysis were two-tailed 
and differences were considered significant when p< 0.05.  
 
2.4 Results and Discussion 
     Our novel synchrotron-based method to measure the height of the airway surface liquid 
layer covering the epithelium lining the lumen of intact, isolated swine trachea takes advantage 
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of the large difference in refractive index between the air and the airway liquid layer, which 
produces a strong signal at the air-liquid interface using phase contrast imaging (PCI, Fig. 2.1a) 
(Lewis et al., 2005; Morgan et al., 2013; Parsons et al., 2008; Siu et al., 2008). The position of 
the tissue was determined using agarose beads (Cash et al., 1979; Chmiel et al., 2002) that 
come into direct contact with the surface epithelium (Fig. 2.S1). The height of the ASL layer 
was measured as the distance between the air-liquid interface and the edge of the agarose bead 
touching the surface epithelium (Fig. 2.1b and Fig. 2.S1) by a researcher blinded from the 
experimental conditions. Preliminary experiments showed that beads larger than 100 µm do 
not migrate during experimentation due to mucociliary clearance. In our experiments we use 
beads larger than 200 µm. 
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Fig. 2.1. Synchrotron-based phase contrast imaging. (a) Schematic showing the detection of ASL–air interface 
in the lumen of an intact trachea using PCI. The synchrotron provides a sufficient amount of parallel spatial 
coherence X-ray to enhance the contrast between air and ASL using PCI. When X-rays pass through the 
preparation, the difference in refractive index between ASL and air results in a phase shift of X-rays that causes 
an interference pattern shown on the detector as variations in X-ray intensity. Since the ASL refractive index is 
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very similar to that of the tissue, PCI cannot resolve the ASL–tissue interface. Thus, we use agarose beads to 
detect the position of the tissue with respect to the ASL–air interface. (b) Measurement of ASL height in an intact 
trachea as the distance between the ASL–air interface (arrow) and the edge of the agarose bead touching the 
surface epithelium by a researcher blinded to the experimental conditions. The agarose bead sits in the ASL layer, 
and the border of the agarose bead is highlighted. The distance from the bottom of the agarose bead to ASL–air 
interface is used to measure the height of the ASL layer. The measured height of the ASL layer in this experiment 
is 115 μm. (c) Frequency distribution and median (dotted line) of ASL height in control tracheas exposed to agar 
beads containing no bacteria for 5 min; n = 117 agarose beads obtained from tracheal preparations from 39 pigs. 
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Fig. 2.S1. Agarose beads come into direct contact with the surface epithelium. The agarose beads that we use for measuring 
airway surface liquid (ASL) layer height must be positioned at either the top or the bottom of the preparation, where the ASL–
air interface is parallel to the X-rays reaching the sample. The position of the beads in the ASL depends on the forces acting 
on them (i.e., gravity, surface tension, and buoyancy); however, buoyancy is a minor force acting on the beads, because the 
beads are loaded with X-ray–absorbing salts with high molecular weight, and the density of the beads exceeds that of the ASL 
(1.3 g cm−3 vs.1 g cm−3) (Lee et al., 2011). As a result, the position of the beads is determined largely by gravity and surface 
tension. Beads located at the bottom of the preparation are subject to both gravity and surface tension pushing them against 
the tissue. For beads located at the top of the preparation, gravity and surface tension will have opposing effects, with surface 
tension pushing the beads against the tissue and gravity pulling away from the tissue. (a and b) Mathematically calculating 
whether surface tension will be sufficient to push the beads against the tissue is difficult; thus, we directly tested whether the 
surface tension of the ASL is sufficient to force the beads located at the top of the preparation up against the tissue. To this end, 
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we placed ASL collected from swine trachea on the underside of a cover glass and immersed agarose beads in it, then imaged 
the preparation with light microscopy (a) and synchrotron-based phase-contrast imaging (b). In this preparation, gravity is 
pushing the beads away from the cover glass, and surface tension of the ASL is pulling them toward the glass. The images 
show that the beads are touching the glass cover, indicating that surface tension is greater than gravity. To further test whether 
the force of gravity affects the position of the beads in the ASL, and thus the ASL height measured, we compared the ASL 
height measurements obtained from beads placed at the top of the preparation and those placed at the bottom. If the force of 
gravity was pushing the beads away from the epithelium, we would expect to see smaller ASL height measurements obtained 
from beads located at the top of the preparation compared with those obtained from beads at the bottom of the preparation. 
Our analysis found no significant differences in ASL measurements from beads at the top and beads at the bottom. (c) 
Scatterplot and median ASL height measured with beads placed at the top and bottom of the preparation (n = 132 for top and 
n = 51 for bottom; P = 0.19, Mann–Whitney test). Thus, the results suggest that the force of gravity does not influence our 
measurements (i.e., ASL surface tension is greater than gravity) and that the measured height of the ASL is not dependent on 
the position of the beads. We performed a final test of whether the beads are in direct contact with the surface epithelium by 
labeling the beads with FITC and labeling the surface epithelium with Rhod-2-AM. A piece of trachea was dissected, as 
described for secretion assays. The mucosal side was incubated in PBS containing Rhod-2-AM (50 μM) and pluronic F-127 
(0.1%) for 30 min, then washed with PBS and dried with a stream of air while the serosal side was incubated in Krebs solution. 
The preparation was then stimulated with carbachol (1 μM on the serosal side) for 20 min, to stimulate ASL secretion by the 
submucosal glands. The FITC-labeled agarose beads were then placed in the ASL, and the preparation was viewed under a 
two-photon excitation microscope. (d) With the aid of a dissecting microscope, we verified that the beads were immersed in 
the ASL. (E) The two photon microscope images showed that the beads (green) and surface epithelium (red) were in direct 
contact (yellow, n = 47 repetitions). 
 
29 
 
     The ASL height on the surface of untreated epithelia showed heterogeneity, as previously 
described using electron microscopy (Sims and Horne, 1977). The ASL layer height ranged 
from 16 to 400 µm with a median height of 77 µm, consistent with previous reports of average 
ASL heights ranging from 3 to 100 µm depending on species and state of the airway (Fig. 2.1e; 
Worthington and Tarran, 2011).  
     To test the effect of P. aeruginosa, agarose beads were loaded with bacteria and instilled 
in the trachea preparation for 35 min. Exposure of the trachea to bacteria-free agarose beads 
for 35 minutes produced a small but significant increase in the height of the ASL (Fig. 2.2a). 
However, when tracheas were exposed to P. aeruginosa-laden agarose beads, ASL secretion 
was much greater (Figs. 2.2b, c). In contrast, tracheal preparations that had been pre-incubated 
for 30 min with the CFTR blocker, CFTRinh172 (100µM), failed to respond to P. aeruginosa 
(Figs. 2.2d, e, f), indicating that P. aeruginosa triggered CFTR-dependent ASL secretion in the 
airways. 
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Fig. 2.2. Bacteria stimulate ASL secretion (a–c), which is inhibited by CFTRinh172 (d–f). (a and b) 
Scatterplot and median of ASL height in tracheas exposed to bacteria-free (a) and P. aeruginosa-laden (b) agarose 
beads. The median ASL height increased from 99 μm to 103 μm after a 35-min incubation with bacteria-free 
agarose beads (n = 18) and from 66 μm to 89 μm after a 35-min incubation with bacteria-laden agarose beads (n 
= 19) (P < 0.05, Wilcoxon signed-rank test). (c) Average increase in ASL height triggered by bacteria-laden (n = 
19) and bacteria-free (n = 18) agarose beads (P < 0.05, Student t test). Columns labeled with different letters differ 
significantly). (d) Scatterplot and median values of ASL heights of tracheal preparations incubated for 30 min 
with CFTRinh172 (100 μM) before exposure to P. aeruginosa-laden agarose beads. The median ASL height did 
not change after a 35-min incubation with bacteria-laden agarose beads in CFTRinh172-treated preparations (n = 
26; P > 0.05, Wilcoxon signed-rank test). The cartilage surrounding the trachea was dissected out to ensure access 
of the blocker. (e) Scatterplot and median values of ASL heights of tracheas that underwent the same surgical 
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procedure as tracheas in D and before exposure to P. aeruginosa-laden agarose beads. The median ASL height 
increased from 86 μm to 143 μm after a 35-min incubation with bacteria-laden beads (n = 26; P < 0.05, Wilcoxon 
signed-rank test). (f) Average increase in ASL height triggered by bacteria-laden beads in CFTRinh172-treated 
and untreated controls (n = 26 for both CFTRinh172 and controls; P < 0.05, Student t test). Columns labeled with 
different letters differ significantly. 
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     Most of the ASL secreted in the upper airways is produced by the submucosal glands, 
with a smaller contribution from surface epithelium cells (Reid, 1960). To test whether the ASL 
produced in response to bacteria comes from submucosal glands, we surgically removed the 
glands from halves of tracheas and compared the ASL secretion with the halves containing 
glands. The segments of the tracheas containing submucosal glands secreted more fluid in 
response to P. aeruginosa (Fig. 2.3a), thus indicating that most of the ASL produced in response 
to bacteria comes from the submucosal glands. Thus, the composition of the ASL secreted in 
response to P. aeruginosa may be similar to the fluid secreted by the submucosal glands, i.e. 
containing 94 mM Na+, 92 mM Cl-, pH 6.97 and many proteins including mucins, lysozyme, 
siderocalin, HSC-71, α-1-antitrypsin and α-1-antichymotrypsin (Jayaraman et al., 2001; Joo et 
al., 2004). 
     To test whether the response to the bacteria involved all glands in the preparation or just 
those in close proximity to the bacteria, we developed a method, based on K-edge subtraction 
(Rubenstein et al., 1986), that allowed us to distinguish bacteria-laden and bacteria-free beads 
in the same preparation (Fig. 2.3b). When we instilled both P. aeruginosa-laden and bacteria-
free agarose beads in a trachea, the bacteria-laden beads showed a much larger increase in ASL 
height after 35 min incubation (Fig. 2.3c). These results indicated that the response to P. 
aeruginosa was not a general response affecting all glands, but rather a local response by 
submucosal glands adjacent to the bacteria (Wine, 2007; Ianowski et al., 2008).  
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Fig. 2.3. Submucosal glands are major contributors to bacteria-stimulated ASL secretion. (a) Tracheas with 
submucosal glands (SMG) surgically removed produced less fluid than tracheas with intact SMG (n = 13 with 
SMG and n = 11 without SMG; P < 0.05, Student t test). Columns labeled with different letters differ significantly). 
(b) Bacteria-free and P. aeruginosa-laden agarose beads were differentially labeled with barium or iodine and 
detected using K-edge subtraction. ASL height was measured at each individual bead by a researcher blinded to 
the experimental conditions. Only bacteria-laden beads showed increases in ASL after a 35-min incubation. On 
average, there were eight agarose beads per trachea, and the average distance between beads was 1.6 mm. (c) 
Increase in ASL height after a 35-min concurrent instillation of bacteria-free and P. aeruginosa-laden agarose 
beads (n = 23 for both groups; P < 0.05, Student t test). Columns labeled with different letters differ significantly. 
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     The detection of P. aeruginosa by the nasal epithelial cell line CF15 requires the 
expression of flagellin, an abundant bacterial structural protein (Hybiske et al., 2004). We 
therefore tested the effect of P. aeruginosa mutant strain PAK∆fliC, which lacks flagellin. 
PAK∆fliC failed to stimulate ASL secretion in swine trachea, compared to the wild-type PAK 
strain (Fig. 2.4a). In addition, agarose beads loaded with flagellin produced similar ASL 
secretion as PAK (Fig. 2.4a). These results suggest that P. aeruginosa must express flagellin in 
order to stimulate ASL secretion.  
     Direct addition of flagellin (10 ng/ml) to the serosal side, i.e. in direct contact with the 
submucosal glands, did not stimulate secretion, while addition of the proinflammatory 
cytokines IL-1β did (50 ng/ml, Fig. 2.4b, Baniak et al., 2012). These results suggest that 
flagellin does not directly stimulate submucosal glands to trigger ASL secretion but that it may 
bind to toll-like receptor-5 (TLR5) in the surface epithelia lining the lumen of the airways and 
trigger one or more paracrine signals such as IL-1β, which, in turn, stimulate submucosal gland 
ASL secretion (Illek et al., 2008). Consistent with this hypothesis, TLR5 expression was 
detected in surface epithelia but not in the submucosal glands using RT-PCR (Fig. 2.4c). In 
addition, RT-PCR shows that submucosal glands express IL-1β receptor, IL-1R1 (Fig. 2.4f). 
IL-1R1 immunostaining colocalizes with lysozyme, a marker for serous cells that are the 
driving force for submucosal gland secretion (Fig. 2.4e). If flagellin does trigger the release of 
paracrine signals to the submucosa, these signals should accumulate in the solution bathing the 
submucosa. To test this hypothesis, we used a modified airway submucosal gland secretion 
assay preparation with intact surface epithelia. We incubated the surface epithelia with P. 
aeruginosa (PAK or PAK∆fliC) or PBS for 35 minutes and then collected the Krebs solution 
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bathing the serosal side of the preparation. We tested the effect of the collected fluid on 
submucosal gland secretion using a secretion assay. The liquid collected from preparations 
incubated with PAK stimulated significantly greater submucosal gland secretion than the liquid 
collected from those incubated with PAK∆fliC or PBS (Fig. 2.4d). Thus, the results suggest 
that flagellin shed by inhaled P. aeruginosa bind TLR5 expressed by the surface epithelium 
cells (Lambrecht and Hammad, 2012) triggering the release of proinflammatory cytokines into 
the submucosa within few minutes (Reiniger et al., 2007). The cytokines diffuse from the 
surface epithelium to the glands located ~150 µm away (Kreda et al., 2005; Ostedgaard et al., 
2011) stimulating CFTR-dependent ASL secretion (Baniak et al., 2012). Flagellin will also 
induce mucin expression within 18-24 h and further contribute to bacteria clearance (Ben 
Mohamed, 2012; Li et al., 1998). 
     Pseudomonas aeruginosa is not the only bacteria encountered by CF patients. Other 
pathogens such as Staphylococcus aureus and Haemophilus influenzae may appear in the 
airways before P. aeruginosa. Thus, we tested whether the airways responded to instillation of 
S. aureus- and H. influenzae-laden agarose beads. The results show that both of these pathogens 
triggered CFTR-dependent ASL secretion (Fig. 2.4g and h). Interestingly, these bacteria do not 
express flagellin, suggesting that there may be other pattern recognition receptor pathways 
involved in triggering CFTR-dependent ASL secretion.  
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Fig. 2.4. P. aeruginosa-triggered ASL secretion requires expression of flagellin. (a) PAKΔfliC-laden agarose 
beads produced less ASL than PAK-laden agarose beads, and flagellin-laden (10 ng/mL) agarose beads (FLA) 
triggered a similar response as PAK-laden beads (n = 12 bacteria-free, n = 7 PAK, n = 10 PAKΔfliC, and n = 15 
FLA; P < 0.05, ANOVA and Bonferroni’s multiple comparison test). Columns labeled with different letters differ 
significantly. (b) Secretion assay data shows that the addition of flagellin (10 ng/mL) to the Krebs solution bathing 
the submucosal glands did not stimulate ASL secretion, whereas the addition of IL-1β (50 ng/mL) did (n = 10 for 
flagellin and n = 9 for IL-1β; P < 0.05, ANOVA and Bonferroni’s multiple comparison test). Columns labeled with 
different letters differ significantly. (c) Airway surface epithelia (Upper) express the flagellin receptor TLR5, 
whereas submucosal glands do not (Lower). The lung is a positive control for TLR5, and + and – indicate RT 
positive and negative, respectively. (d) The Krebs solution bathing the submucosa of trachea preparations 
incubated with P. aeruginosa strain PAK on the mucosal side stimulated ASL secretion in a secretion assay, 
whereas PAKΔfliC and PBS did not (n = 9 for all groups; P < 0.05, ANOVA and Bonferroni’smultiple comparison 
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test). Columns labeled with different letters differ significantly. (e) Confocal immunofluorescence of IL-1β 
receptor IL-1R1 (Left), lysozyme (Middle), and both merged (Right) in submucosal glands. The images show that 
IL-1R1 is colocalized with lysozyme, a marker for serous cells. (f) Airway submucosal glands express IL-1R1. 
The heart is a positive control for IL-1R1, and + and − indicate RT positive and negative, respectively. (g and h) 
Bacteria-triggered ASL secretion is not limited to P. aeruginosa. Both S. aureus (g) (n = 8 bacteria-free, n = 10 S. 
aureus, and n = 12 S. aureus + CFTRinh172; P < 0.05, ANOVA and Bonferroni’s multiple comparison test) and 
H. influenzae (h) stimulate ASL secretion that is inhibited by CFTRinh172 (n = 19 bacteria-free, n = 11 H. 
influenzae, and n = 10 H. influenzae + CFTRinh172; P < 0.05, ANOVA and Bonferroni’s multiple comparison 
test). Columns labeled with different letters differ significantly. 
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     Our results are the first demonstration that bacteria-triggered, CFTR-dependent ASL 
secretion is part of the normal innate immune response to inhaled bacteria. CFTR is required 
for normal fluid secretion, which washes mucins and antimicrobial compounds from the 
submucosal glands into the airway lumen (Ianowski et al., 2007; Joo et al., 2010; Joo et al., 
2002; Wine, 2007; Martens et al., 2011; Baniak et al., 2012; Reid, 1960; Ianowski et al., 2008). 
The loss of CFTR-mediated fluid secretion reduces ASL secretion, supporting the hypothesis 
that CFTR mutations lead to reduced secretion of antimicrobial compounds and mucins into 
the lumen of the airway which facilitate chronic infection and inflammation (Pezzulo et al., 
2012; Sun et al., 2010; Cho et al., 2011; Meyerholz et al., 2010). Eventually the airway 
undergoes remodeling, including goblet cell hyperplasia, and more severe pathologies such as 
mucus hypersecretion (Stoltz et al., 2010). These results suggest that the progression of cystic 
fibrosis airway disease may be ameliorated by treatments that improve the response of the 
airways to inhaled bacteria, such as prophylactic antibiotic treatment. In addition, abnormal 
ASL secretion in response to microbes may contribute to other pathological conditions such as 
COPD and asthma where airway remodeling occurs and responses to microbes could be 
blunted (Matkovic and Miravitlles, 2013). 
     Finally, the synchrotron-based technique we have developed is applicable to living 
animals (Luan et al., 2013), thereby making it possible to study the response to bacteria in 
animal models of CF in vivo and the effect of treatments such as CFTR trafficking correctors. 
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Chapter 3 
Cystic fibrosis swine fail to secrete airway surface liquid in response to inhalation of 
pathogens 
     Citation: Luan X, et al. (2017) Cystic fibrosis swine fail to secrete airway surface liquid 
in response to inhalation of pathogens. Nat Commun 8(1):786. 
     Disclaimer: Manuscript has been reformatted for consistency with the dissertation, 
including some rearrangement. References have been moved to the end of the dissertation as 
per CGSR requirements. No other content has been changed. 
 
3.1 Abstract 
     Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis 
transmembrane conductance regulator channel, which can result in chronic lung disease. The 
sequence of events leading to lung disease is not fully understood but recent data show that the 
critical pathogenic event is the loss of the ability to clear bacteria due to abnormal airway 
surface liquid secretion. However, whether the inhalation of bacteria triggers airway surface 
liquid secretion and whether this is abnormal in cystic fibrosis has never been tested. Here we 
show, using a novel synchrotron-based in vivo imaging technique, that wild-type pigs display 
both a basal and a toll-like receptor-mediated airway surface liquid secretory response to the 
inhalation of cystic fibrosis relevant bacteria. Both mechanisms fail in CFTR-/- swine, 
suggesting cystic fibrosis airway do not respond to inhaled pathogens, thus favoring infection 
and inflammation that may eventually lead to tissue remodeling and respiratory disease。  
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3.2 Introduction 
     Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in 
CFTR gene. Although CF is a multisystemic disease, much of the morbidity and mortality 
arises from lung disease (Stoltz et al., 2015). CF patients can develop chronic bacterial 
pulmonary infections and inflammation that may eventually cause end-stage lung disease. 
However, the sequence of events that result in lung disease from cystic fibrosis transmembrane 
conductance regulator (CFTR) mutations is not fully understood. Recent data show that the 
first outcome of CFTR mutation is an impaired ability to eliminate bacteria. Lungs from CF 
animal models (F508del and CFTR-/- pigs) (Ostedgaard et al., 2011; Stoltz et al., 2010) fail to 
purge bacteria as effectively as wild-type littermates before the development of inflammation 
(Stoltz et al., 2010; Pezzulo et al., 2012). These results suggest that impaired bacterial 
elimination is the pathogenic event initiating a cascade of inflammation and pathology in CF 
lungs (Stoltz et al., 2010).  
     The failure to clear bacteria seems to result from abnormal airway surface liquid (ASL) 
layer in the CF lung (Sun et al., 2010; Joo et al., 2010; Joo et al., 2002; Ianowski et al., 2007). 
The ASL is a complex mixture of water, salts, gel-forming mucins, and antimicrobial 
compounds that contribute to trapping, inactivating, killing, and clearing pathogens through 
mucociliary clearance (Knowles and Boucher, 2009; Smith et al., 1996; Roy et al., 2014). 
Airway samples from CF patients (Joo et al., 2002), 1-day old CFTR-/- piglets (Joo et al., 2010), 
newborn CFTR-/- ferrets (Sun et al., 2010), and CFTR-/- mice (Ianowski et al., 2007) fail to 
respond to stimulatory signals that normally elicit strong ASL secretion (Wine, 2007; 
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Widdicombe and Wine, 2015; Ballard and Inglis, 2004; Baniak et al., 2012), suggesting that 
CF airway would fail to respond to inhaled insults (Sun et al., 2010; Joo et al., 2010; Joo et al., 
2002; Ianowski et al., 2007). It has therefore been proposed that CF airway may fail to secrete 
ASL in response to bacterial inhalation, thus reducing the amount of antimicrobial compounds 
and mucin available in the airway, compromising mucociliary clearance and facilitating 
infection and inflammation (Pezzulo et al., 2012; Joo et al., 2010; Joo et al., 2002; Ianowski et 
al., 2007; Baniak et al., 2012; Marten et al., 2011; Ianowski et al., 2008). However, whether 
inhalation of bacteria triggers ASL secretion and whether this response is abnormal in CF lungs, 
has never been tested. We used CFTR-/- swine (gut-corrected CFTR-/-, see “Materials and 
Methods” section) to study how CF airway respond to inhalation of bacteria in vivo, where all 
components of the regulatory mechanisms are intact, i.e., autonomic (Wine, 2007), sensory 
efferent (Widdicombe and Wine, 2015), and immune signals (Ballard and Inglis, 2004; Baniak 
et al., 2012). Our results show that there are a basal and a bacteria-triggered TLRs-related ASL 
secretory responses in the airway of wild-type swine. Both responses are missing in CFTR-/- 
swine, which do not display basal secretion nor respond to inhalation of Pseudomonas 
aeruginosa. The results suggest the missing ASL secretory responses in CF airway leads to 
bacteria clearance failure, which further results in facilitating infection and inflammation. 
 
3.3 Materials and Methods 
Animals 
     We used gut-corrected CFTR-/- swine purchased from Exemplar Genetics (Iowa, USA) 
and wild-type swine from Prairie Swine Center (University of Saskatchewan) that served as 
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controls. 
     A sow implanted with cloned embryos with the gut-corrected CFTR-/- genotype 
(CFTR-/- ;TgFABP > pCFTR pigs) (Stoltz et al., 2013) was purchased from Exemplar Genetics. 
The sow was housed at the Western College of Veterinary Medicine Animal Care Unit, 
University of Saskatchewan, for 4 weeks before due date to allow the sow to acclimate to the 
new environment and reduce stress during delivery. To reduce exposure to bacteria in the birth 
canal and to minimize the stress of natural birth on the piglets, the delivery was done through 
a cesarean section performed by a specialized veterinary surgeon team to ensure minimal 
exposure of the piglets to anesthetics. 
     The sow delivered 11 male piglets of normal weight (Table 3.S1). Each newborn animal 
was identified with a number and monitored 24 h a day. Food intake, urination, passing and 
consistency of feces, temperature, weight, respiratory function, O2 saturation, body condition, 
and responsiveness were recorded for each piglet (Table 3.S1). Animal number 11 showed 
reduced O2 saturation at birth that did not improve. Thus we decided to image it (this data was 
not included in our data set), and euthanized the animal 12 h after birth. Animals 3, 4, 5, 7, and 
10 started to display deterioration of health status 48 h after birth, so we decided to image the 
animals and euthanized them. Animals 2, 6, and 8 displayed health deterioration 5 days after 
birth; thus, we imaged and euthanized the animals. Animals 1 and 9 reached the end of the 
experimental period at day 7 after birth. The control experiments were performed using 7 days 
old wild-type swine 3– 5 kg in weight (Prairie Swine Center, University of Saskatchewan). For 
ex vivo experiments, tracheas from CFTR-/- and wild-type animals where dissected within 15-
30 minutes of euthanasia, clamped, and placed in ice-cold Krebs-Ringer solution (mM): 115 
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NaCl, 2.4 K2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 1.2 MgCl2, 25 NaHCO3, 10 glucose (pH=7.4) 
equilibrated with 95% O2, 5% CO2 until used. All experiments were performed within 18 h 
after euthanasia. All of the experiments were performed under the approvals of the Canadian 
Light Source and the Animal Ethics Committee of the University of Saskatchewan. 
 
Analysis of CFTR expression in the gut  
    The CFTR expression correction in the gut of gut-corrected CFTR-/- swine piglets was 
tested by qPCR analysis as described before (Stoltz et al., 2013). Gut tissue (from pig #7 and a 
wild-type pig) was dissected, flash frozen in liquid nitrogen, and stored at -80oC. The samples 
were later thawed in RNA-Ice (Ambion Cat # AM7030) overnight. Approximately 120-150 mg 
of the thawed tissue was used to extract total RNA using the Purelink RNA mini kit (Ambion 
Cat# 12183025).  RNA quality was checked on a BioAnalyzer (Agilent) to ensure that RNA 
templates used in downstream applications had a RIN > 8.0 and was not contaminated with 
genomic DNA. First strand cDNA was synthesized from approximately 1µg of total RNA using 
random primers provided in the Superscript IV First Strand Synthesis Kit (ThermoFisher Cat# 
18091050). RT-qPCR reactions were carried out using Taqman expression assays and probes 
(CFTR: Ss3389420_m1, β actin: Ss03376160_u1, ThermoFisher) previously used to measure 
CFTR mRNA levels in the CFTR-/- pigs (Stoltz et al., 2013). qPCRs were done on a CFX96 
thermocycler (BioRad) and analyzed using the CFX manager software. Samples were run in 
quadruplicates. 
     qPCR results showed that CFTR mRNA levels (normalized to β-actin) in the gut of pig#7 
was 23.29% that of wild-type (Fig 3,S1), which is consistent with what has been previously 
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reported (Stoltz et al., 2013).  
 
Pathology analysis of CFTR-/- swine 
     After euthanasia, the carcasses were subjected to pathology analyzes by a board-certified 
veterinary pathologist. Gross examinations were conducted on each carcass. Tissues included 
brains (pigs #4, 5, 7, 10, and 11 only), eyes (pigs #4, 5, 7, 10, and 11, only), hearts, spleens, 
kidneys, livers, and pancreas (pigs #8 and 11 only), small and large intestines were fixed in 10% 
formalin for haematoxylin and eosin staining and histological examination.  
     On gross examination (Table 3.S2), the colon and cecum in 7 out of 10 pigs were 
distended by feces that was firmer than normal (Fig. 3.S2A). Four pigs that were euthanized 
later in the experiment showed cranioventral consolidation of the lung. Four pigs had 
gallbladders that were small (hypoplasia) on gross examination. In pig #10, the common bile 
duct was blocked by a thick mucus plug. Two pigs had increased amount of mucus in their 
nasal cavities compared to the other pigs (Fig. 3.S2B). On histological examination, the 
pancreases were hypoplastic (Fig. 3.S2C). Three pigs had evidence of cholestasis. The 
pneumonia was characterized by severe infiltration of neutrophils mixed with many bacteria in 
the alveoli and bronchiole (Fig. 3.S2D).  Brains, eyes, hearts, spleens, kidneys, small and 
large intestines were normal histologically. 
 
X-ray Imaging 
Experiments were performed at the BioMedical Imaging and Therapy (BMIT) facility, 
Canadian Light Source (CLS), Saskatchewan, Canada (Wysokinski et al., 2007). All imaging 
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was done using the Bending Magnet (BM) beamline 05B1-1 endstation. The experimental 
hutch was located 25.5 meters from the storage ring. Monochromatic x-rays (33.5 keV, λ=0.037 
nm for live swine experiments, and 20 KeV, λ=0.062 nm for isolated trachea experiments) were 
selected using a standard double-crystal monochromator. At the imaging station, the beam size 
was approximately 100.0 mm horizontal x 6.0 mm vertical. A propagation (sample-to-detector) 
distance of ~115 cm (in vivo) and ~ 65 cm (ex vivo) were chosen to enhance the air/ASL layer 
interface. Images were captured using a charge-coupled device (CCD) detector (C9300-124 
Hamamatsu Photonics) with a high resolution X-ray converter (AA-60 Hamamatsu Photonics). 
The pixel size of the captured image was 8.75 x 8.75 μm. The exposure time for each image 
ranged from 400 to 600 ms depending on the storage ring current so as to maximize signal-to-
noise ratio for image capturing. 
 
Evaluation of agarose beads-epithelium interaction 
     We used agarose beads as “measuring rods” to determine the height of the ASL layer. 
ASL height was measured as the distance between the air/ASL interface and the edge of the 
agarose bead touching the surface epithelia. The validity of our measurement relies on the fact 
that the agarose beads instilled in the ASL do indeed come into physical contact with the airway 
surface epithelium and are immobilized (Luan et al., 2014). We therefore conducted a series of 
experimental tests and theoretical analysis to test whether the beads are in fact immobilized on 
the surface of the airway epithelia. 
     Agarose beads immersed in the airway surface liquid are subjected to two major forces 
that determine the stability of the beads: gravity and the surface tension created by the ASL. At 
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the dorsal (bottom, in supine position) surface of the trachea, both gravity and surface tension 
force the beads towards the surface epithelium (see Fig. 3.2c in main text); as a result, the beads 
are forced against the airway surface epithelium as long as the bead diameter is larger than the 
ASL thickness.  
     For the beads placed on the ventral (top) surface of the trachea, gravity acts to pull the 
bead away while ASL surface tension forces the bead towards the surface epithelium. In this 
case, the net force on the bead determines whether the bead would come into contact with the 
airway surface epithelium. We thus decided to produce a mathematical model of the bead-
ASL/epithelium interaction to determine whether the beads were in contact with the epithelium 
under our experimental conditions.  
     The adhesion force due to surface tension and capillary forces on the bead (Fig. 3.1) can 
be calculated as: (Schurch et al., 1990; Rapacchietta et al., 1977). Fγ = 2πRγ sinϕ sin(θ + ϕ)                                      1 
Where R is the radius of the agarose bead, γ is surface tension of ASL, δ is the height of the 
ASL layer in the trachea, z0 is the meniscus depth of ASL due to the capillary effect of liquid 
around the agarose bead, θ is the contact angle between ASL and agarose. cosϕ = 1 − 𝛿𝛿
𝑅𝑅
−
𝑧𝑧0
𝑅𝑅
                                              2 
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Fig. 3.1. Diagram of an agarose bead immersed in ASL. The diagram shows the force due to surface tension 
and the capillary forces acting on the bead, and the parameters relevant to Eq. (3). Where R is the radius of the 
agarose bead, γ is the surface tension of ASL, δ is the height of the ASL layer in the trachea, z0 is the meniscus 
depth of the ASL due to the capillary effect of liquid around the agarose bead, θ is the contact angle between the 
ASL and the agarose. Our analysis shows that under our experimental conditions, the net effect of gravity and 
surface tension push the beads against the epithelium without causing significant tissue displacement. 
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From equation #1 and 2: Fγ = 2πRγ sin �cos−1 �1 − 𝛿𝛿+𝑧𝑧0𝑅𝑅 �� sin �θ + cos−1 �1 − 𝛿𝛿+𝑧𝑧0𝑅𝑅 ��      3 
     To resolve equation 3, we obtained airway fluid surface tension values (γ), previously 
reported to range from 30 to 34 mN/m (Hamed and Fiegel, 2013). We used the average value 
of 32 mN/m in our calculations. We measured the contact angle (θ) between the agarose and 
the ASL using a goniometer (Yuan and Lee, 2013). A droplet of swine trachea ASL was placed 
on a flat surface of 4% agarose, and the contact angle between the ASL and the 4% agarose 
was directly recorded to be 44° ± 1.6°. 
     Inputting these values to equation #3, we obtain: Fγ = 2πR ∙ 32 mN/m ∙ sin �cos−1 �1 − 𝛿𝛿+𝑧𝑧0𝑅𝑅 �� sin �44° + cos−1 �1 − 𝛿𝛿+𝑧𝑧0𝑅𝑅 ��     4 
     We can assume for now that z0 will be small compared to the thickness (averaging 93 
µm) of the fluid layer. However, the thinner the ASL is, the more important z0 becomes. And 
larger z0 value would cause larger surface tension on the bead. Since z0 would have minimal 
effect in our case, we simplified the force calculation to equation 5, where we underestimate 
the surface tension generated by ASL. Fγ = 2πR ∙ 0.032 N/m ∙ sin �cos−1 �1 − 𝛿𝛿𝑅𝑅�� sin �44° + cos−1 �1 − 𝛿𝛿𝑅𝑅��         5 
     Now there are only 2 variables; bead radius, R, and ASL layer height, δ.  
     Supplementary Fig. 3.S3 below shows the change in adhesion force, within the range of 
ASL thickness observed in swine trachea, 20 to 300 µm, with varying bead size and fluid 
thickness. The data show that negative adhesion, i.e. the bead would move away from tissue, 
occurs when the bead is fully submerged in the fluid. In that condition, the surface tension force 
would be considered nil, and gravity, G = 4/3ρ𝜋𝜋𝑟𝑟3 , would force the bead away from the 
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epithelium. The results show that beads with a range of diameters used in our experiments, 400 
to 1000 µm, will touch the epithelium even with an ASL height as little as 2 µm (Supplementary 
Fig. 3.S3). Thus, under all our experimental conditions, the net effect of gravity and surface 
tension push the beads against the epithelium. 
     We also tested whether the forces acting on the agarose beads were strong enough to 
push the beads into the airway surface epithelium and deform the tissue, which would affect 
our measurements. The deformation of the trachea surface epithelia caused by the force applied 
on the tissue is related to the elasticity of the tissue (Van Vlierberghe et al., 2014). 
     We measured the elasticity of swine trachea by measuring the amount of force required 
to displace the tracheal tissue (Van Vlierberghe et al., 2014; Tay et al., 2006). The forces that 
cause varying displacement for trachea fall into a linear function, and the measured spring 
constant κ of swine trachea was 7.6 N/m. The displacement of tracheal epithelium by beads of 
varying sizes and and varying ASL layer thickness can be calculated from equation #6 . 
𝑑𝑑 = 𝐹𝐹𝑛𝑛𝑛𝑛𝑛𝑛 𝜅𝜅⁄                                                       6 
Where d is the displacement of trachea tissue, Fnet is the net force on the agarose bead (for the 
beads at top of trachea, 𝐹𝐹𝑛𝑛𝑛𝑛𝑛𝑛 = Fγ-G; for the beads at bottom of trachea, 𝐹𝐹𝑛𝑛𝑛𝑛𝑛𝑛=Fγ+G), and κ 
is the spring constant of swine trachea we measured. 
     The results indicate that displacement of airway epithelia by agarose beads would not be 
larger than 12 µm (Fig. 3.S4 and S5), which is within the range of the error of our measurments. 
Therefore, tissue displacement is unlikely to affect our measurements of ASL height. 
     We conducted experimental tests to determine whether the agarose beads in our 
experiments are in contact with the surface epithelia. Our results show that, as indicated by our 
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mathematical model, the beads indeed contact the epithelia. Initially, we placed agarose beads 
in an ASL sample collected from isolated trachea and placed it on the underside of a glass slide. 
The agarose beads were forced against the glass surface, indicating that the surface tension 
from the ASL is stronger than gravity and forces the beads up against the glass surface, as 
predicted by the mathematical model (Fig. 3.S6).  
     Histological evidence also supports the fact that the agarose beads are in direct contact 
with the surface epithelia.  Agarose beads were instilled into freshy harvested trachea of 1 
week old wild-type piglets. The preparations were flash frozen in liquid nitrogen and stored at 
-80oC. Then, the trachea preparations were cryo-sectioned into 20 µm sections and stained with 
Nuclear Fast Red (Sigma) for 1 minute, which delineated the airway tissue. The sections were 
imaged on a light microscope. Histological images (n=11) clearly showed that the agarose 
beads were indeed in contact with the airway surface epithelium (Fig. 3.S7). 
     We also tested the prediction that tissue displacement by beads does not affect our 
measurements of the ASL height. First, if displacement of the tissue by beads did affect our 
ASL height measurements, one would expect that the ASL heights measured from beads 
located at the top part of the trachea, where gravity and surface tension act in opposite 
directions, would be smaller than those obtained from beads located at the bottom part of the 
trachea, where both gravity and surface tension push the beads into the tissue. Our analysis of 
the data collected shows that ASL measurements obtained from top and bottom of the trachea 
were not significantly different (Fig. 3.S8). 
     In addition, since the tissue displacement depends on bead size (Figs. 3.S4 and S5), we 
would expect that, if tissue displacement affects our measurements, bead size would influence 
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the ASL height measured. A small bead would cause less tissue displacement than a larger bead. 
As such, we should expect a correlation between bead size and the ASL height measured (Fig. 
3.S9) or the change in ASL in 30 min (Fig. 3.S10). However, our data showed no such 
correlations between ASL height or change in ASL and bead size. Indicating that tissue 
displacement does not affect our ASL measurements. 
     Thus, using a range of theoretical and experimental evidence, we confirm that beads 
instilled in the ASL experience sufficient surface tension force that immobilize them against 
the airway, without significantly deforming the epithelium or affecting ASL measurement.  
 
Preparation of agarose beads  
     Agarose beads were made in sterile conditions with 4% agarose in PBS as described 
elsewhere (Luan et al., 2014; Cash et al., 1979; Chmiel et al., 2002). Agarose beads were not 
only used as vehicles to deliver bacteria into trachea but were also used as “measuring rods” to 
determine the height of the ASL layer. Insoluble BaSO4 or CuI (1 M) was loaded into the 
agarose beads to make them visible in x-ray imaging without affecting the osmotic pressure of 
the beads (Luan et al., 2014). Bacteria-free agarose beads were made from sterile PBS alone; 
and bacteria-laden agarose beads were made by adding 10% v/v of bacterial stock solution.  
     P. aeruginosa stock solution was made with a clinical isolate, P. aeruginosa (NH57388) 
(Hoffmann et al., 2005), generously provided by Dr. John Gordon at the University of 
Saskatchewan. Clinical isolates of H. influenzae and S. aureus were generously provided by 
Dr. Joseph Blondeau at the Royal University Hospital, Saskatoon, Saskatchewan, Canada. E. 
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coli DH5-α was provided by Dr. Gordon at the University of Saskatchewan, and B. subtilis was 
purchased from Cedarlane (Burlington, Ontario, Canada).  
     Aliquots of the P. aeruginosa clinical isolate, the P. aeruginosa PAK and PAKΔfliC 
strains, S. aureus clinical isolate, and E. coli DH5-α were inoculated in Erlenmeyer flasks 
containing growth media, and incubated for ~24 h at 37ºC with shaking at 170 rpm in an aerobic 
environment. An aliquot of the H. influenzae clinical isolate was incubated for ~24 h at 37ºC 
with shaking at 170 rpm in an anaerobic environment, and an aliquot of B. subtilis was 
incubated for ~24 h at 26ºC with shaking at 170 rpm in an aerobic environment. All bacterial 
cultures except E. coli and B. subtilis were then heat killed (by incubating at 80ºC for 30 min), 
concentrated by centrifuging, and then stored at -20ºC. Prior to use, pathogen concentrates were 
thawed and mixed with agarose; whereas non-pathogens (E. coli DH5-α and B. subtilis) were 
directly concentrated from bacterial culture aliquots before use.  
 
Experimental set-up 
     For the in vivo experiments, the animal was placed in supine position on a warming pad 
and anesthetized with 2-2.5% isoflurane in pure medical O2 through a face mask at an air flow 
rate of 1 liter per min. Throughout the experiment, the animals breathe spontaneously. 
Respiratory rate, heart rate, body temperature, and O2 saturation level as well as the plane of 
anesthesia were monitored. The agarose beads with diameters ranging from 400 to 1000 μm 
where instilled into the trachea of the animal using an endotracheal tube. Before inserting the 
endotracheal tube, the larynx was sprayed with lidocaine to prevent a reflex response to 
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intubation. The agarose beads were then blot-dried and placed in the endotracheal tube. The 
endotracheal tube was placed at the opening of the larynx into the trachea and the beads were 
blown with a puff of air out of the tube and into the trachea, after which the endotracheal tube 
was immediately removed. Images were taken at 5 and 35 min after the agarose beads were 
placed in the trachea.  
     For ex vivo experiments (Luan et al., 2014), tracheas were dissected from recently 
euthanized animals and placed in a custom-built chamber wherein the tissue was immersed in 
Krebs solution plus 1 μM indomethacin at 35ºC and equilibrated with 95% O2 and 5% CO2. 
The trachea was sealed so that the lumen remained free of the solution but it was accessible for 
introduction of beads. Agarose beads ranging ~400 to 1000 μm in diameter were blotted dry 
and placed in the lumen of the airway.  
     The air-ASL interface can be detected only at the ventral (top) and at the dorsal (bottom) 
of the trachea, where the direction of the x-rays propagation is parallel to the plane of the air-
ASL interface because only these regions generate x-ray phase shifts that produce a strong 
signal in phase contrast x-ray imaging (Fig. 3.1b). We therefore used a computer-controlled 
motorized stage to rotate the animal to ensure the beads were positioned appropriately before 
imaging. The ASL height was measured 5 and 35 min after instillation of the beads. The 
measurements made at 5 min were interpreted as the original state of ASL, i.e. before exposure 
to bacteria. We labeled the first time point as 5 min (instead of 0) to reflect the time delay 
between instillation of the beads and acquisition of the first image. 
     Both bacteria-free and bacteria-laden beads were instilled in each experiment (in vivo 
and ex vivo) to control for differences in response among preparations. We distinguished 
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bacteria-laden beads from bacteria-free beads using K-edge subtraction that allows us to 
determine iodine from barium labeled beads (Rubenstein et al., 1986). Iodine K-edge 
subtraction imaging was performed using monochromatic 33.20 keV and 33.35 keV beams. 
Barium K-edge subtraction imaging was performed using monochromatic 37.50 keV and 37.65 
keV beams. 
 
Secretion assays 
     A sample of trachea was cut along the trachealis muscle, and the airway submucosa 
containing the glands was dissected from the cartilage (Luan et al., 2014). This submucosa 
preparation was placed in a custom built chamber with the serosal side bathed in Krebs solution 
containing 1 μM indomethacin (Joo et al., 2001). The preparation was maintained at 37ºC and 
equilibrated with warm, humidified 95% O2 and 5% CO2 gas (TC-102, Medical Systems Corp., 
Greenvale, NY, US). The mucosal side was cleaned, dried with a stream of air, and coated with 
~5 μl mineral oil. The ASL secreted by the submucosal glands formed a spherical droplet under 
the mineral oil. Cytokines interleukins 6 or 8 were added to the serosal side. The droplets of 
ASL secreted by the glands were imaged every 120s and stored for offline analysis using 
ImageJ 1.43u (NIH). The volumes of the secreted droplets were calculated assuming a spherical 
shape (V = 4/3πr3) (Joo et al., 2001). The secretion rate was calculated by fitting the volume 
versus time plots with straight lines using linear regression, and the slopes were taken as the 
secretion rates using at least four points (Joo et al., 2002).  
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Surgical removal of the submucosal glands 
     The cartilage was removed from a tracheal preparation using a scalpel and a blunt-ended 
elevator (Luan et al., 2014). Once the cartilage was removed, the submucosal glands and other 
tissue in the submucosa were dissected out by "shaving" with a breakable scalpel blade (Fine 
Science Tools, Vancouver, Canada). As described previously (Luan et al., 2014), Ussing 
chamber and secretion assay experiments showed that our procedure allowed us to remove 90% 
of glands from the trachea without damaging the surface epithelia.  
 
Reagents 
     CFTRinh-172, SQ22536, and flagellin from Salmonella typhimurium were obtained 
from Cedarlane Labs (Burlington, ON, CA). Atropine and lipopolysaccharide from P. 
aeruginosa were purchased from Sigma-Aldrich; tetrotoxin was purchased from Alomone labs 
(Jerusalem, Israel); lidocaine hydrochloride 12mg/metered dose was obtained from Odan 
Laboratories LTD (Montreal, Canada). Stock solutions of CFTRinh-172, SQ22536, and were 
dissolved in DMSO. The final concentration of DMSO was less than 0.1%. Atropine, flagellin 
and lipopolysaccharides were dissolved in milli-Q water.  
 
Statistics 
     Data are presented as mean ± SEM. The data sets that met the assumption of normality 
and homogeneity of variances where analyzed with parametric tests, ANOVA or Student’s t-
test. For those that did not, we performed non-parametric tests, Wilcoxon match-pairs signed 
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rank test or Mann–Whitney U-test, using GraphPad Prism 5 (GraphPad Software Inc., San 
Diego, CA, USA), and P < 0.05 was considered significant. Preliminary experiments showed 
that a sample size of 6 was sufficient to ensure adequate power to detect the effects of treatment 
on ASL secretion. Animal #11 was not included in the study because it never recovered from 
the stress of delivery. We did not exclude any data collected from any of the animals studied 
from our analysis. 
 
Data availability 
     The authors declare that all the data supporting the findings of this study are available 
within the article and its Supplementary Information files. 
 
3.3 Result  
Synchrotron-based x-ray phase contrast imaging 
     The main challenge in studying airway secretion in vivo is the lack of an imaging method 
with sufficient contrast and resolution to observe the thin ASL layer (93 ± 8 μm thick, see Fig. 
3.2) that is constantly cleared out of the airway through mucociliary clearance. We developed 
a synchrotron-based x-ray imaging technique to measure the ASL layer in vivo. The technique 
exploits the large difference in x-ray refractive index between the air and the ASL layer, which 
generates a strong signal at the air/ASL interface under x-ray phase contrast imaging (PCI) (Fig. 
3.2b) (Luan et al., 2014; Lewis et al., 2005). Because PCI does not allow us to observe the 
ASL/tissue interface, we used agarose beads instilled into the swine airway as ‘measuring rods’ 
to measure the ASL height by determining the position of the tissue with respect to the air/ASL 
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interface (Fig. 3.2b, c, see “Materials and Methods” section). A researcher blinded to the 
experimental conditions measured ASL height as the distance between the air/ASL interface 
and the edge of the agarose bead touching the surface epithelium (Fig. 3.2b). The surface 
tension of the ASL immobilizes the beads onto the surface of the epithelium (“Materials and 
Methods”). The liquid secreted by the airway, which would normally be cleared out by 
mucociliary clearance, is retained around the static bead, allowing us to measure the 
accumulation of the ASL secreted by the airway (Luan et al., 2014). Another advantage of 
agarose beads is that they can be used as a pathogen delivery system by loading the beads with 
CF relevant bacteria, such as P. aeruginosa. 
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Fig. 3.2. Synchrotron-based phase contrast imaging. a) Schematic of the in vivo imaging set up. b) Detection 
of the air/ASL layer interface in the lumen of swine trachea in vivo. When x-ray (undisturbed) pass through the 
trachea, the difference in refractive index between the ASL and the air in the lumen results in a phase shift of the 
x-ray (distorted wavefront), which is detected by phase contrast imaging (PCI). PCI cannot resolve the ASL/tissue 
interface because the ASL refractive index is very similar to that of the tissue. Thus we used agarose beads as 
“measuring rods” to determine the position of the tissue with respect to the air/ASL interface. In the phase contrast 
image obtained in vivo (grayscale image on right panel), the air/ASL interface is clearly observable as a dark line 
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(highlighted with dotted line). The edge of the agarose bead is outlined by the dotted circle. The distance from the 
bottom of the agarose bead to air/ASL interface is used to measure the height of the ASL layer. Note that the 
air/ASL interface is below the level of the meniscus formed by the ASL on the agarose bead. Scale bar represents 
500 μm. c) Schematic diagram illustrating the forces acting on the agarose bead (surface tension and gravity) and 
the bead–tissue interaction. d) Frequency distribution and mean (93 ± 8 μm, indicated by arrow) of ASL height in 
wild-type swine trachea exposed to bacteria-free agarose beads in vivo (n = 39 agarose beads obtained from 24 
wild-type live pigs). 
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Absent ASL secretion in response to inhaled bacteria in CF 
     We studied airway ASL secretory response to inhaled bacteria in anesthetized, 2–7-days-
old CFTR-/- and wild-type swine. Our analyses indicate that the trachea of wild-type animals 
have a basal level of ASL secretion that increased by 100% after instillation of P. aeruginosa-
laden agarose beads (Fig. 3.3a–c). In contrast, exposure to P. aeruginosa-laden beads failed to 
increase ASL secretion in CFTR-/- swine (Fig. 3.3d–f). These results show that ASL secretion 
is indeed upregulated by bacterial inhalation, revealing a previously unknown component of 
the airway’s innate immune response. This response is absent in CF airways, which would 
result in reduced bacterial clearance, thus facilitating infection. 
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Fig. 3.3. CFTR-/- swine fail to respond to Pseudomonas aeruginosa in vivo. Scatter plot and median (red line) 
of the effect of a) bacteria-free and b) bacteria-laden agarose beads on the ASL layer of wild-type swine. Bacteria-
free beads trigger an ASL increase from 105 to 123 µm (p < 0.05, n=10 from 7 pigs, Wilcoxon match-pairs signed 
rank test) while bacteria-laden beads triggered a height increase from 117 to 168 µm (p < 0.05, n=10 from 6 pigs, 
Wilcoxon match-pairs signed rank test). c) Increase in ASL height triggered by bacteria-laden (n=10) and bacteria-
free (n=10) agarose beads (p < 0.0001, t=7.76 df=18, unpaired Student’s t test). Effect of d) bacteria-free and e) 
bacteria-laden agarose beads on the ASL layer of CFTR-/- swine. Bacteria-free beads trigger an ASL increase from 
172 to 178 µm (p < 0.05, n=9 from 6 pigs, Wilcoxon match-pairs signed rank test) while bacteria-laden beads 
triggered a height increase from 150 to 158 µm (p < 0.05, n=11 from 8 pigs, Wilcoxon match-pairs signed rank 
test). f) The increase in ASL height triggered by bacteria-laden (n=11) and bacteria-free (n=9) agarose beads were 
not significantly different in CFTR-/- swine (p =0.4943, unpaired Mann-Whitney test). Data is presented as mean 
± SEM and columns labeled with different letters differ significantly. 
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     To understand the lack of response in CF lungs, we investigated the mechanism(s) 
underlying P. aeruginosa-mediated ASL secretory response.  Pathogen detection in the airway 
requires the activation of Pattern Recognition Receptors (PRRs), which in turn trigger more 
specific innate immune responses (Kawai and Akira, 2010). For instance, in CF15 cells, the 
response to P. aeruginosa is mediated by the activation of Toll-Like Receptor (TLR) 5 by the 
bacterial protein flagellin, and bacteria strains that lack flagellin (i.e. PAK∆fliC) fail to elicit 
any response (Hybiske et al., 2004). Similarly, our results show that PAK∆fliC bacteria fail to 
trigger ASL secretion in vivo, whereas beads loaded with flagellin alone produced the same 
stimulatory effect as P. aeruginosa (Fig. 3.4a). These data suggest that airway response to P. 
aeruginosa is primarily mediated by stimulation of PRRs by flagellin. Because other relevant 
CF pathogens such as Staphylococcus aureus and Haemophilus influenzae do not express 
flagellin, we tested whether these pathogens stimulate ASL production. We found that S. 
aureus- and H. influenzae-laden beads also stimulated ASL secretion in wild-type swine (Fig. 
3.4b). In addition, beads loaded with lipopolysaccacharide (LPS), a common PRR stimulating 
endotoxin present in S. aureus and H. influenzae, also triggered similar ASL secretory 
responses in wild-type trachea (Fig. 3.4b). Interestingly, introducing beads loaded with the non-
pathogenic bacteria Escherichia coli (DH5-α) and Bacillus subtilis failed to stimulate airway 
ASL secretory response (Fig. 3.4c). These data indicate that bacteria triggered-ASL secretion 
is an innate immune response specific to pathogens and occurs via the activation of TLRs, 
which would lead to the production of proinflammatory cytokines, e.g. interleukin (IL) 1β, 
TNFα, 6 and 8 that stimulate ASL secretion (Baniak et al., 2012; Luan et al., 2014; Illek et al., 
2008; Mohamed et al., 2012; Reiniger et al., 2007). In CF airways, pathogen inhalation would 
63 
 
stimulate TLRs and trigger proinflammatory signals (Bartlett et al., 2016); however, IL-1β, and 
TNF-α (Baniak et al., 2012), IL-6, and IL-8 (Fig. 3.4d and f) fail to trigger ASL secretion and 
clear pathogens, thus facilitating infection and inflammation. 
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Fig. 3.4. Stimulation of pattern recognition receptors trigger ASL secretion in wild-type swine in vivo. a) P. 
aeruginosa PAK strain-laden agarose beads (PAK) significantly stimulates ASL secretion. PAKΔfliC-laden 
agarose beads (ΔfliC), which lacks flagellin, induce much less ASL secretion. Flagellin-laden (10 ng/ml) agarose 
beads (FLA) triggered a similar response as PAK beads (n = 11 bacteria-free from 6 pigs, n = 10 PAK from 6 pigs, 
n = 10 ΔfliC from 7 pigs, and n = 8 FLA from 5 pigs; p < 0.0001, F (3, 35) = 36.59, ANOVA and Tukey’s multiple 
comparison test). b) S. aureus-(SA) and H. influenzae-laden (HI) agarose beads stimulate ASL secretion in wild-
type swine. Similarly, LPS (20 µg/mL)-laden beads produce a similar effect (n = 10 bacteria-free from 7 pigs, n 
= 7 S. aureus from 4 pigs, n = 7 H. influenzae from 4 pigs, and n = 7 LPS from 5 pigs; p =0.0003, F (3, 27) = 8.79, 
ANOVA and Tukey’s multiple comparison test). c) The non-pathogenic B. subtilis (BS)- and E. coli (EC)-laden 
agarose beads failed to trigger ASL secretion in wild-type swine (n = 10 bacteria-free from 6 pigs, n = 7 E. coli 
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DH5-α from 5 pigs, and n = 7 B. subtilis from 6 pigs; p =0.3369, F (2, 21) = 0.40, ANOVA and Tukey’s multiple 
comparison test). Secretion assay data showed that d) IL-6 (50 ng/mL, n =16 preparations from 7 CFTR-/- animals 
and n = 9 preparations from 4 wild-type animals,  p < 0.0001, F (3, 60) = 12.79, ANOVA and Tukey’s multiple 
comparison test) and f) IL-8 (50 ng/mL, n =15 for CFTR-/- airway tissue from 7 pigs and n = 10 for wild type 
tissue from 4 pigs, p < 0.0001, F (3, 56) = 13.09, ANOVA and Tukey’s multiple comparison test) failed to trigger 
submucosal gland secretion in CF tissue, but stimulated ASL secretion in wild-type airway. Data is presented as 
mean ± SEM and columns labeled with different letters differ significantly. 
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Reduced basal ASL secretion in CF 
     The ability of CF airways to clear pathogens may also be compromised by a reduction 
in basal ASL secretion, i.e., background ASL production independent of bacteria inhalation. 
Indeed, using bacteria-free agarose beads, we detected a basal ASL secretion rate both in wild-
type and CFTR swine in vivo, however, the basal ASL secretion by CFTR swine was 
significantly smaller (Fig. 3.5a). Therefore, we decided to study the source of this secretion and 
its regulation. Our results show that basal ASL secretion is produced by submucosal glands, 
and surgical removal of over 90% of the submucosal glands from wild-type ex vivo tracheal 
preparations significantly reduced ASL secretion (Fig. 3.5b). These results are consistent with 
previous reports that more than 90% of ASL produced in the upper airway is secreted by the 
submucosal glands (Ballard and Inglis, 2004). Treatment of wild type ex vivo tracheal 
preparations with the CFTR inhibitor, CFTRinh172, blocked basal ASL secretion (Fig. 3.5c), 
reinforcing that CFTR-mediated glandular secretion is the source of basal ASL production in 
the trachea.  
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Fig. 3.5. CF tissue fail to produce basal ASL secretion. a) CFTR-/- swine (CF, n=9 from 6 animals) display 
significantly lower basal ASL secretion than wild-type swine (n=10 from 7 animals, mean ± SEM, p =0.0010, 
unpaired Mann-Whitney test).  b) Wild-type ex vivo preparations with surgically removed submucosal glands 
(SMG) produced significantly lower basal ASL (n=12 with SMG from 6 preparations and n=13 without SMG 
from 6 preparations, p <0.0001, unpaired Mann-Whitney test). c) Wild-type ex vivo preparations incubated with 
the CFTR anion channel blocker, CFTRinh172 (100 µM), produced significantly lower basal ASL than non-
treated preparations (Control, n=6 from 4 preparations for control, and n=14 from 5 preparations for CFTRinh172, 
p <0.0001, unpaired Mann-Whitney test). d) Inhibition of sensory neurons with topical application of lidocaine 
(Lido) had a small effect on basal ASL secretion. Simultaneous treatment with the CFTR inhibitor (Lido + inh172) 
completely blocked basal ASL secretion (mean ± SEM, n=13 control from 5 preparations, n=21 Lido from 8 
preparations, and n=16 Lido+inh172 from 7 preparations; p < 0.0001, F (2, 47) = 59.35, ANOVA and Tukey’s 
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multiple comparison test). e) Blocking neuronal function with tetrodotoxin (1µM, TTX) treatment had no effect 
on basal ASL secretion (mean ± SEM, n=18 control from 8 preparations, and n=11 TTX from 4 preparations, 
p=0.5820, unpaired Mann-Whitney test). Blocking cholinergic receptors with atropine had no effect on basal ASL 
secretion in f) ex vivo preparations (10µM, n=8 without Atropine from 3 preparations and n=8 with Atropine from 
4 preparations, p=0.7656, t=0.3040 df=14, unpaired Student’s t test) or g) in vivo wild-type swine (treated with 
0.04mg/kg IM 2-10 minutes following induction of anesthesia, n=8 without Atropine from 6 animals, and n=10 
with Atropine from 7 animals, p=0.7538, t=0.3191 df=16, unpaired Student’s t test). h) Inhibiting cAMP 
production with the adenylyl cyclase inhibitor, SQ22536 (0.5 mM), blocked basal ASL secretion (n=10 control 
from 4 preparations and n=11 SQ22536 from 4 preparations; p =0.0003, unpaired Mann-Whitney test). Data is 
presented as mean ± SEM and columns labeled with different letters differ significantly. 
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     It is possible that spontaneous ASL secretion could be a reactive response of sensory 
neurons to the presence of agarose beads. We tested this by blocking sensory neurons in ex vivo 
trachea preparations with the topical anesthetic lidocaine, which caused a slight reduction in 
basal secretion, but not to the extent that would explain loss of secretion in CF tissues (Fig. 
3.5d). ASL secretion may also be stimulated by airway intrinsic neurons (Widdicombe and 
Wine, 2015). Thus, we treated preparations with tetrodotoxin, a Na+ channel blocker that 
inhibits airway intrinsic neuron function (Allen and Burnstock, 1990), which had no discernible 
effect on basal ASL secretion (Fig. 3.5e). We also tested whether parasympathetic tonic 
stimulation may drive basal secretion by treating airways with the cholinergic antagonist, 
atropine (Ueki et al., 1980). The treatment had no effect on secretion in vivo or ex vivo (Fig. 
3.5f and g), indicating that basal secretion is independent of neuronal activation (i.e. 
parasympathetic, sensory efferent, and airway intrinsic neurons). However, blocking cAMP 
production with the adenylate cyclase blocker, SQ22536, significantly reduced basal secretion 
ex vivo (Fig. 3.4h), suggesting that a cAMP-mediated regulatory mechanism modulates basal 
secretion that is independent of the nervous system.  
 
3.4 Discussion      
     This study provides evidence of previously unknown components of the airway innate 
immune response to pathogens. We describe a basal level of ASL secretion that perhaps 
performs a “housekeeping” function (Wine, 2007) by ensuring a basal presence of mucins and 
antimicrobial compounds in the airway, which may be the only protection against non-
pathogenic particles. In addition, the airway has a pathogen-triggered ASL secretion response 
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at the site of infection through paracrine stimulation of ASL secretion by cytokines (Joo et al., 
2010; Joo et al., 2002; Ianowski et al., 2007; Wine, 2007; Baniak et al., 2012; Martens et al., 
2011; Ianowski et al., 2008). The lack of basal secretion in CF airway would result in reduced 
ASL availability to deal with inhaled particles, which combined with the lack of response to 
pathogens would severely undermine the innate immune system’s ability to protect the airway 
from inhaled insults. Instead, pathogens would activate PRRs and production of 
proinflammatory signals, thus favoring inflammation (Pezzulo et al., 2012; Sun et al., 2010; 
Cho et al., 2011). Finally, our results suggest that treatments which improve the basal ASL 
secretion, such as hypertonic saline nebulization, or treatments that protect the airway from 
inhaled bacteria, such as prophylactic antibiotics, would slow the progression of CF airway 
disease. 
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3.6 Supplemental data  
Table 3.S1. Summary of clinical histories of the gut-corrected CFTR-/- piglets.  
Wt- Weight kg. HR- Heart rate. O2- % oxygen saturation. Temp- Temperature in degree Celsius. IC- Intestinal 
complications. RS- Respiratory Symptoms. 
 
 
 
Pig# Vital signs at birth Treatments Euthanasia 
 Wt  HR O2 Temp some offered more than once Age Reason 
1 1.13 158 99 37.6 1ml enema (oil) 7 days elective 
2 1.43 172 99 37.8 2.5ml enema (water-oil) 5 days IC, RS. 
3 1.14 149 96 36.7 5% dextrose IP 5cc 2 days IC 
4 1.47 136 96 35.6 5% dextrose IP 5cc 2 days IC 
5 1.18 153 90 36.9 5% dextrose IP 5cc, 2.5ml enema 
(water-oil) 
2 days IC 
6 1.47 176 92 38.2 1ml enema (oil) 5 days IC, RS. 
7 1.25 193 95 37.2 5% dextrose IP 5cc, 2.5ml enema 
(water-oil) 
2 days RS 
8 1 198 88 37.7 2.5ml enema (water-oil) 5 days IC 
9 1.37 170 85 37.8 1.5 ml enema (oil) 7 days elective 
10 1.55 171 93 37.3 2.5ml enema (water-oil) 2 days IC 
11 1.26     12 h RS 
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Fig. 3.S1. CFTR mRNA levels (relative to β-actin) in CF gut corrected (CFTR-/-) and Wild-type (WT) pigs. 
Values are shown as percentage mRNA levels relative to the wild-type. Samples were run in quadruplicates. qPCR 
results showed that CFTR mRNA levels (normalized to β-actin) in the gut of pig#7 was 23.29% that of wild-type, 
which is consistent with what has been previously reported (Stoltz et al., 2013). 
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 Table 3.S2. Summary of gross and histological findings 
+: present, -: absent, NA: observation not available 
 
 
 
Pig 
ID 
Distended 
colon and 
cecum with 
firmer than 
normal feces 
Hypoplastic 
gall bladder 
Common 
bile duct 
blocked by 
thick bile 
Suppurative 
pneumonia 
Notable 
excessive 
mucous in 
nasal cavity 
Prominent 
bile stasis 
Pancreatic 
hypoplasia 
1 - + - + - - NA 
2 + + - + - + NA 
3 NA NA NA NA NA NA NA 
4 + - - - - - NA 
5 + + - - - - NA 
6 + - - + - - NA 
7 - - - - - - NA 
8 + + - - + + + 
9 - + - + + - NA 
10 + - + - - + NA 
11 + - - - - - + 
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Fig. 3.S2. Pathology analysis of gut-corrected CFTR-/- swine. The carcasses of 10 animals were subjected to 
pathology analyses by a board-certified veterinary pathologist. A) Intestines: The cecum and spiral colon are 
severely distended by feces. B) Head: The nasal cavity contains excessive mucous (arrow). C) Pancreas: The acini 
(black arrows) are mostly devoid of zymogen granules, and the interstitium contain increase amount of fibrous 
tissues (white arrows). D) Lung: The bronchiole (arrow) and alveoli are filled with many inflammatory cells, 
mostly neutrophils. Scale bars indicate 100 µm.   
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Fig. 3.S3. Maximum diameter of beads that will be forced against the epithelium at the top of the trachea 
at a given range of ASL layer thickness. The data shows the change in adhesion force, within the range of ASL 
thickness (20 to 300 µm) observed in swine trachea, with varying bead size and fluid thickness as calculated from 
equation 5. 
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Fig. 3.S4. Tissue deformation in the top part of the trachea for given ASL thicknesses and bead diameters. 
The displacement of tracheal epithelium by beads of varying sizes and under varying ASL layer thicknesses can 
be calculated from equation 6 . Tissue displacement is negligible compared to the height of the ASL layer in live 
swine trachea. 
77 
 
 
Fig. 3.S5. Tissue deformation of the bottom part of the trachea for given ASL thicknessnes and bead 
diameters. The displacement of tracheal epithelium by beads of varying sizes and under varying ASL layer 
thicknesses can be calculated from equation 6 . Tissue displacement is negligible compared to the height of the 
ASL layer in live swine trachea. 
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Fig. 3.S6. Surface tension force the beads against the glass slide. We placed agarose beads in an ASL sample 
collected from isolated trachea and placed it on the underside of a glass slide. The agarose beads were forced 
against the glass surface, indicating that the surface tension from the ASL is stronger than gravity and it forces the 
beads up against the glass surface, as predicted by the mathematical model A) Light, and B) phase contrast images 
of the same bead immersed in ASL(Luan et al., 2014). Scale bar represents 500 µm.   ` 
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Fig. 3.S7. Cryo-section of a tracheal preparation showing an agarose bead in contact with airway surface 
epithelia. Agarose beads were instilled into freshly harvested trachea of 1 week old wild-type piglets. The 
preparations were flash frozen in liquid nitrogen and stored at -80 °C. Then, the trachea preparations were cryo-
sectioned into 20 µm sections and stained with Nuclear Fast Red (Sigma) for 1 minute, which delineated the 
airway tissue. The sections were imaged on a light microscope. Histological images (n=11) clearly showed that 
the agarose beads were indeed in contact with the airway surface epithelium. Scale bar represents 500 µm 
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Fig. 3.S8. Scatterplot and mean (red lines) ASL height measured with beads placed at the top and bottom 
parts of live swine trachea (n = 13 for top and n = 18 for bottom; t = 0.1239, df = 29, p = 0.90, Students’ t-test). 
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Fig. 3.S9. Scatterplot and linear regression of bead diameter vs ASL height measured 5 min after incubating 
tissues with bateria-free beads. The linear regression was not significant (p = 0.77, F = 0.087, DFn = 1, DFd = 
29; r2 = 0.003) 
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Fig. 3.S10. Scatterplot and linear regression of bead diameter vs change in ASL height after 30 min of 
incubation with bacteria-free beads. The linear regression was not significant (p = 0.84, F = 0.038, DFn = 1, 
DFd = 29; r2 = 0.001). 
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Chapter 4 
Nebulized hypertonic saline triggers active liquid secretion by airway epithelia in swine 
 
4.1 Abstract  
     Background: Inhaled hypertonic saline (HTS) treatment is used to improve lung health 
in patients with cystic fibrosis. However, the mechanisms underlying the effect of this treatment 
are not fully understood, which makes it difficult to develop procedures to modulate the 
duration and intensity of the treatment to improve outcomes. The current consensus is that the 
treatment generates an osmotic gradient that draws water into the airways and increases the 
airway surface liquid (ASL) volume. However, there is evidence that hypertonic saline may 
also stimulate active secretion of ASL by airway epithelia through the activation of sensory 
neurons.  
     Objective: We tested the contribution of the nervous system and airway epithelia on 
HTS-stimulated ASL production using a novel synchrotron-based method to visualize and 
measure ASL in isolated swine trachea.  
     Results: We found that blocking the nervous system with tetrodotoxin and lidocaine 
reduced HTS-stimulated ASL secretion by 50%. Similarly, incubating the preparations with 
blockers known to inhibit ion transport across the airway epithelia; i.e. CFTRinh172, 
bumetanide and niflumic acid in bicarbonate free saline; resulted in a 50% decrease in response 
to HTS treatment.  
     Conclusion: Hypertonic saline treatment of the airway epithelia triggers both neuron-
mediated ASL secretion and osmotically driven fluid production. It might be possible to 
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modulate the duration and intensity of HTS treatment by pharmacologically altering the 
function of airway neurons and epithelia. 
 
4.2 Introduction 
     Inhaled hypertonic saline (HTS) is a well-established treatment for patients with cystic 
fibrosis (Donaldson et al., 2006; Elkins et al., 2006; Wark and McDonald, 2009). HTS 
treatment has been shown to improve mucociliary clearance, forced expiratory volume in 1 s, 
frequency of exacerbations, days on antibiotics, and well-being (Donaldson et al., 2016, Elkins 
et al., 2006; Tildy and Rogers, 2015; Reeves et al., 2015). Recent analyses of lung clearance 
index and spirometry data for patients under long-term HTS treatment suggest that HTS 
treatment may be able to halt the progression of mild CF lung disease (Ellemunter et al., 2016). 
     The exact mechanism of action of HTS is not understood (Tildy and Rogers, 2015), which 
makes it difficult to develop procedures to modulate the duration and intensity of the treatment 
to improve outcomes (Tang et al., 2016; Cazzarolli et al., 2016; Bennett et al., 2015). The 
current consensus on the mechanism of action of HTS inhalation is that the treatment generates 
an osmotic gradient that draws water into the airways. This increases the volume of airway 
surface liquid (ASL), improves mucus rheological properties, and accelerates mucus transport 
rates (Tildy and Rogers, 2015; Reeves et al., 2015).  
     However, there is evidence that HTS may also stimulate sensory nerves in the airways, 
triggering neurogenic inflammation and stimulating ASL secretion by airway epithelia. In rat 
airways, treatment with HTS stimulates neurogenic inflammation, specifically through the 
local release of inflammatory mediators by sensory-efferent pathways (Umeno et al., 1990; 
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Barnes, 2001; Barnes, 1998; Maggi et al., 1995). In guinea pig airways, HTS treatment 
activates airway afferent nerves including Aδ and C fibers both in vitro and in vivo (Pedersen 
et al., 1985; Fox et al., 1995). Treatment of the nasal cavity with HTS in healthy volunteers 
stimulates nociceptive nerves and glandular mucus exocytosis (Baraniuk et al., 1999). In 
addition, HTS induces robust reflex responses in the nose and larynx of guinea pigs, similar to 
that evoked by capsaicin, and evokes coughing when applied topically to the tracheal or 
laryngeal mucosa (Chou et al., 2008). Furthermore, neurogenic inflammation triggers ASL 
secretion by airway submucosal glands (Widdicombe and Wine, 2015; Ianowski et al., 2008), 
and in ferret trachea, HTS stimulates the production of two markers of gland secretion, mucins 
and lysozyme (Kishioka et al., 2003). 
     We thus tested the role of airway neurons in HTS-stimulated ASL production in tracheas 
isolated from pigs using a novel synchrotron-based imaging method, which we developed to 
measure and quantify ASL secretion in isolated intact tracheas (Luan et al., 2014). Our results 
show that HTS-stimulated ASL production is partially blocked, i.e. ~50% reduction, by 
inhibiting either neuronal function or epithelial ASL secretion. These results suggest that part 
of the ASL produced by HTS treatment is the result of the sensory-efferent stimulation of 
epithelial ASL secretion.  
 
4.3 Materials and Methods 
     Tracheas were obtained from 4-week-old juvenile female and male pigs (15 to 25 kg) 
purchased from the Prairie Swine Centre, University of Saskatchewan. The tracheas were 
dissected within 30 minutes of euthanasia, clamped at both ends to prevent liquid entering the 
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lumen and placed in ice-cold Krebs-Ringer saline solution containing 115 mM NaCl, 2.4 mM 
K2HPO4, 0.4 mM KH2PO4, 1.2 mM CaCl2, 1.2 mM MgCl2, 25 mM NaHCO3 and 10 mM 
glucose (pH 7.4), equilibrated with 95% O2 and 5% CO2 until use. For the bicarbonate-free 
Krebs-Ringer saline solution, 25 mM NaHCO3 was replaced with 24 mM NaCl and 1 mM 
HEPES, pH 7.4, equilibrated in O2 (Wine et al., 2011). Both solutions had similar osmotic 
pressures of 270 ± 0.7 and 269 ± 0.5 (n = 6).  
 
Synchrotron-based x-ray imaging set-up 
     Experiments were performed using the BioMedical Imaging and Therapy-Bending 
Magnet (BMIT-BM) beamline 05B1-1, at the Canadian Light Source (CLS), Saskatchewan, 
Canada. The experimental hutch is located 25.5 meters away from the storage ring. Phase 
contrast imaging (PCI) was performed using monochromatic 20 keV (λ=0.062 nm) x-rays, 
selected using a standard double-crystal monochromator. The beam size was 100.0 mm (wide) 
x 8.0 mm (vertical). The distance between the sample and the detector was 65 cm. Images were 
captured using a high-resolution x-ray converter (AA-60, Hamamatsu Photonics, San Jose, CA, 
USA) with a charge-coupled device (CCD) detector (C9300-124, Hamamatsu Photonics, San 
Jose, CA, USA). The converter used a 10 μm-thick scintillator (Gd2O2S:Tb) to convert x-rays 
to visible light, which was then directed to the CCD. The pixel size of the image was 8.75 x 
8.75 μm. Exposure time ranged from 600 to 900 ms.  
 
Agarose bead preparation 
     We used agarose beads as ‘measuring rods’ to determine the height of the ASL layer, 
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which was measured as the distance between the air/ASL interface and the edge of the agarose 
bead touching the surface epithelia (Fig. 4.1, see supporting information). Agarose beads were 
made in sterile conditions with 4% agarose in PBS (Luan et al., 2014; Cash et al., 1999; Chmiel 
et al., 2002). All solutions used in the process of making agarose beads were autoclaved at 
250°C for at least 20 min. Warm (50-55°C) 4% agarose solution was made in PBS. The agarose 
solution was mixed with warm (50-55°C) heavy paraffin oil and stirred rapidly, achieving a 
vortex 2 cm in depth. The agarose/oil mixed solution was left in a beaker for 11 min, and then 
ice was slowly added around the beaker for 7 min. After 7 min of cooling, the agarose/oil 
solution was poured into a separatory funnel containing warm (50-55°C) 0.5% w/v sodium 
deoxycholate in PBS to wash the mineral oil from the beads. The agarose beads were allowed 
to settle and then washed 3 times with PBS at room temperature to wash away the sodium 
deoxycholate. The upper one third of agarose beads at the bottom of the separatory funnel were 
then taken and used for the experiments. 
     In order to make the beads visible by x-ray, we added BaSO4 (nominal 1 M) as contrast 
agents to the PBS. This salt was chosen because it is insoluble in water and thus does not 
contribute to the osmotic pressure of the bead. The osmolarity of the beads solution were 278 
± 0.1 and 276 ± 0.3 for PBS and PBS plus 1M BaSO4, respectively (Luan et al., 2014).  
 
Experimental set-up 
     The trachea preparation was clamped at both ends so that the lumen was filled with air. 
The cartilage was removed with the aid of a scalpel and a fine blunt-ended elevator to improve 
access of the drugs to the epithelia and nervous tissue. The trachea preparation was placed in a 
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custom-built chamber. The tissue was immersed in Krebs solution plus 1 μM indomethacin at 
35ºC and equilibrated with 95% O2 and 5% CO2. The lumen of the trachea preparation 
remained free of solution and sealed, yet was accessible to the researchers to introduce the 
agarose beads. Agarose beads (~200 to 800 μm in diameter) were blotted dry and placed in the 
lumen of the preparation using a cotton swab. Each bead was placed at a location where the 
air/ASL interface is parallel to the x-rays penetrating the sample, i.e. the top or bottom of the 
preparation (Fig. 4.1) (Luan et al., 2014), using a motorized computer-controlled experimental 
stage. Hypertonic (7% NaCl solution w/v) and isotonic (0.9% NaCl solution w/v) saline 
treatments were administered using a nebulizer (705-445, AMG Medical Inc, Montreal, 
Quebec, Canada), which produces liquid aerosols with a median diameter of 4 μm. The 
nebulizer was connected to a ventilator (687 mouse ventilator, Harvard Apparatus, St. Laurent, 
Quebec, Canada) that delivered the aerosols to the tracheal preparation for a period of 90 s with 
a frequency of 40 strokes per minute. Each stroke was 30 ml. Hypertonic saline or ITS 
treatment began at time 0. Images were captured 3 minutes before treatment (-3 min), and 6, 
12, and 18 minutes after treatment.  
 
Reagents 
     The drugs were obtained from Sigma-Aldrich unless otherwise stated. CFTRinh172 was 
purchased from Cedarlane Labs (Burlington, ON, CA), tetrodotoxin was obtained from 
Alomone labs (Jerusalem, Israel), and lidocaine hydrochloride spray was acquired from Odan 
Laboratories LTD (Montreal, Canada). Stock solutions of CFTRinh172, atropine, bumetanide, 
niflumic acid, and L-703606 were dissolved in DMSO. The final concentration of DMSO was 
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less than 0.1%. Tetrodotoxin was directly dissolved into purified water.  
 
Statistics 
     Data are presented as mean ± SEM. The two-way ANOVA analysis and Tukey’s multiple 
comparisons test was done using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, 
US), with p < 0.05 considered significant. 
 
Study approval 
     All experiments were performed with the approval of the Canadian Light Source and the 
Animal Ethics Committee at the University of Saskatchewan. 
 
4.4 Results 
     We have developed a synchrotron-based imaging method to measure and quantify ASL 
secretion in intact airways (Luan et al., 2014). We exploited the large refractive index difference 
between the air and the airway surface liquid (ASL) layer, which produces a strong signal at 
the air/ASL interface using phase contrast imaging (PCI) (Fig. 4.1A) (Donnelley et al., 2014; 
Morgan et al., 2013). Because PCI does not allow us to observe the ASL/tissue interface to 
determine the ASL height, we determined the position of the tissue with respect to the air/ASL 
interface using agarose beads as “measuring rods”. The agarose beads are instilled in the ASL 
and come into direct contact with the surface epithelium due to the force generated by the 
surface tension of the ASL (see supporting information). The surface tension of the ASL 
immobilizes the beads on the surface of the epithelium (i.e. beads are not cleared away by 
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airway cilia), and the liquid secreted by the airway, which would normally be cleared from the 
airway due to mucociliary clearance, is retained around the static bead, allowing us to measure 
the accumulation of the ASL produced by fluid secretion. A researcher blinded to the 
experimental conditions measures the height of the ASL layer as the distance between the 
air/ASL interface and the edge of the agarose bead touching the surface epithelium (Fig. 4.1B) 
(Luan et al., 2014). 
     Tracheal preparations had the cartilage removed to expose the submucosal glands and 
the nervous tissue to the bathing fluid, and the preparations were fitted to a custom-built 
chamber that maintained the tissue immersed in Krebs solution bath while the lumen of the 
trachea preparation remained free of solution and accessible to the researchers. The preparation 
was attached to a ventilator connected to a nebulizer. Hypertonic (7%) or isotonic (0.9%) saline 
was applied to the lumen of the preparation using the nebulizer and ventilator arrangement (Fig. 
1A). The height of ASL layer was measured 3 min before treatment and 6, 12, and 18 min after 
nebulization (time 0) (Fig. 4.1C).  
     As expected, treatment of swine airway with HTS significantly increased ASL 
production when compared to preparations nebulized with isotonic saline (ITS) and 
preparations without treatment (control) (Fig. 4.1D). HTS caused a significant increase in ASL 
secretion within 6 minutes after treatment that persisted for the remainder of the experiment. 
The ASL layer also increased in both the ITS and control groups, but the difference between 
the groups was not significant. This would suggest that there is a basal level of ASL secretion 
in the isolated airway.  
91 
 
 
Fig. 4.1. Experimental design and phase contrast imaging using synchrotron x-rays. (A) Schematic showing 
the set up for the detection of air-ASL interface in the lumen of an intact trachea using phase contrast imaging. 
When x-rays pass through the preparation, the difference in refractive index between the ASL and the air results 
in a phase shift of x-rays that causes a distinct interference pattern detected as variations in x-ray intensities on 
the CCD. The trachea preparation was set up in a custom build chamber that was connected to a nebulizer and a 
ventilator apparatus. (B) Synchrotron-based phase contrast imaging measurement of ASL height in an isolated 
swine trachea. (C) HTS or ITS aerosol were delivered at time 0 for 90 seconds, and images were acquired at time 
-3, 6, 12, and 18 minutes. (D) Treatment with HTS stimulated higher ASL secretion compared to preparations 
treated with ITS and control preparations (HTS, n = 45 beads from 15 tracheas; ITS, n = 49 beads from 14 tracheas; 
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control, n = 12 beads from 5 tracheas). Data is presented and the statistical analyses were performed on an 
individual bead measured value basis. Data is presented as mean ± SEM and were analyzed by two-way ANOVA 
and Tukey’s multiple comparison test. The error bars are small and hidden behind the symbols. Data sets labeled 
with different letters differ significantly, p < 0.05. 
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HTS-triggered ASL secretion is partially mediated by the nervous system 
     Since previous reports indicated that HTS stimulates neurogenic inflammation (Umeno 
et al., 1990), we tested the effect of blocking the nervous system in airways treated with HTS. 
Incubating airways in tetrodotoxin (TTX, 1µM) and lidocaine (luminal spray of 80 mg/ml 
solution) blocks both the voltage-dependent sodium channels (Scholz et al., 1998; Brau et al., 
2000) expressed by neurons intrinsic to the airways and the TTX-independent sodium channels 
expressed by sensory neurons of the airways (Widdicombe and Wine, 2015; Wine, 2007). 
These results show that blocking neuronal function with lidocaine+TTX reduces the effect of 
HTS treatment by ~50% (Fig. 4.2A). In contrast, lidocaine+TTX treatment had no effect on 
ITS-treated preparations (Fig. 4.2A). We also tested whether lidocaine may have non-specific 
inhibitory effects on epithelial cells. It has shown that exposure to bacteria stimulated ASL 
secretion independently of the nervous system (Luan et al., 2017). Using similar procedures 
(Luan et al., 2014), we determined that lidocaine-treated preparations showed no reduction in 
bacteria-stimulated ASL response (data not shown), rejecting any non-specific inhibitory 
effects of lidocaine on epithelial function. These results suggest that blocking neuronal function 
specifically abrogates HTS-triggered ASL production, which is consistent with the hypothesis 
that neurogenic inflammation plays a role in the response to HTS treatment.  
     To evaluate the effect of HTS treatment in CF airways, we used the CFTR blocker 
CFTRinh172 (100 µM) to model airways without CFTR function (Melis et al., 2014). HTS 
treatment in preparations incubated with CFTRinh172 (HTS+172) was less effective in 
stimulating ASL production than preparations not incubated in CFTR blocker (HTS). However, 
it still stimulated higher ASL production than ITS treatment (ITS+172, Fig. 4.2B). This result 
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concurs with previous experiments showing that HTS treatment improves ASL hydration in CF 
patients (Robinson et al., 1996; Robinson et al., 1997). Interestingly, CFTRinh172 treatment 
reduced ASL secretion in ITS-treated samples (ITS+172) below that of ITS treatment in control 
preparations (ITS, Fig. 4.2B), suggesting that the trachea has a basal level of CFTR-dependent 
ASL secretion.  
     Preparations incubated with CFTRinh172 suffered a reduction in the response to HTS 
treatment when neuronal function was blocked with lidocaine+TTX (Fig. 4.2C). In contrast, 
ITS-treated preparations were not affected by lidocaine+TTX (Fig. 4.2C). These results suggest 
that HTS treatment, but not ITS, increases ASL secretion through stimulation of sensory and/or 
airway intrinsic neurons in CF airways.  
     Since there is evidence that HTS treatment triggers substance P (SP) release (Baraniuk 
et al., 1999), and that SP can stimulate ASL secretion by airway epithelia in the trachea of 
several species (Ianowski et al., 2008; Choi et al., 2009; Khansaheb et al., 2011), we tested the 
effect of a SP receptor (neurokinin 1 receptor, NK-1) blocker, L-703606 (1 µM) on HTS-
stimulated ASL production. The results show that treatment with L-703606 (HTS + NK-1 
Blocker) significantly reduced HTS-triggered ASL production, but had no effect on the ITS 
treatment group (ITS + NK-1 Blocker, Fig. 4.2D). However, HTS treatment of preparations 
incubated with CFTRinh172 was unaffected by the NK-1 blocker (Fig. 4.2E), indicating that 
the SP-mediated HTS-triggered effect is CFTR dependent and may be absent in CF airways.  
     We then tested the possible role of muscarinic stimulation on HTS-triggered ASL 
secretion. Blocking muscarinic receptors with atropine (1µM) reduced HTS-triggered ASL 
secretion but had no effect on ITS treated samples (Fig. 4.2F). Atropine also reduced the 
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response to HTS treatment in preparations incubated with the CFTR blocker, CFTRinh172, but 
had no effect on ITS-treated preparations. These results suggest that in CF airways, HTS 
treatment stimulates neuronal release of cholinergic signals and the production of active ASL 
secretion by airway epithelia. 
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Fig. 4.2. HTS stimulates ASL secretion via activation of sensory neurons and release of acetylcholine in CF 
airways. (A) Treatment with lidocaine (Lido, 80mg/ml aerosol) plus tetrodotoxin (TTX, 1µM) blocked HTS-
triggered ASL secretion but had no effect in ITS-treated preparations (HTS, n = 45 beads from 15 tracheas; ITS, 
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n = 49 beads from 14 tracheas; HTS+Lido+TTX, n = 18 beads from 4 tracheas; ITS+Lido+TTX, n = 9 beads from 
4 tracheas). (B) Incubation with CFTRinh172 (172, 100µM) reduced the effect of HTS treatment. However, HTS 
treatment still produced more ASL than ITS treatment (HTS, n = 45 beads from 15 tracheas; ITS, n = 49 beads 
from 14 tracheas; HTS+172, n = 59 beads from 12 tracheas; ITS+172, n = 29 beads from 8 tracheas). (C) 
Incubation with lidocaine plus TTX blocked the response of CFTRinh172-treated airway to HTS, but had no effect 
on ITS treated preparations (HTS+172, n = 59 beads form 12 tracheas; HTS+172+Lido+TTX, n = 9 beads from 
4 tracheas; ITS+172, n = 29 beads form 8 tracheas; ITS+172+Lido+TTX, n = 21 beads from 6 tracheas). (D) The 
substance P receptor blocker, L-703606 (NK-1 Blocker, 1µM), reduced the response to HTS treatment but had no 
effect on ITS treated samples (HTS, n = 45 beads from 15 tracheas; ITS, n = 49 beads form 14 tracheas; HTS+NK-
1 Blocker, n = 36 beads form 12 tracheas; ITS+NK-1 Blocker, n = 16 beads from 5 tracheas). (E) CFTRinh172-
treated preparations did not respond to the NK-1 blocker (HTS+172, n = 59 beads from 12 tracheas; 
HTS+172+NK-1Blocker, n = 10 beads from 4 tracheas; ITS+172, n = 29 beads from 8 tracheas; ITS+172+NK-1 
blocker, n = 17 beads from 6 tracheas). (F) Blocking muscarinic receptors with atropine (1 µM) significantly 
reduced the effect of HTS treatment but had no effect on ITS treated preparations (HTS, n = 45 beads from 15 
tracheas; ITS, n = 49 beads form 14 tracheas; HTS+Atropine, n = 22 beads from 5 tracheas; ITS+Atropine, n = 
11 beads from 4 tracheas). (G) Atropine (1 µM) blocks the effect of HTS treatment but does not affect ITS 
treatment in preparations incubated in CFTRinh172 (HTS+172, n = 59 beads from 12 tracheas; 
HTS+172+Atropine, n = 18 beads from 5 tracheas; ITS+172, n = 29 beads from 8 tracheas; ITS+172+Atropine, 
n = 19 beads from 5 tracheas). Data is presented and the statistical analyses were performed on an individual bead 
measured value basis. Data are presented as mean ± SEM and were analyzed by two-way ANOVA and Tukey’s 
multiple test. The error bars are small and hidden behind the symbols. Data sets labeled with different letters differ 
significantly, p < 0.05.  
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HTS treatment triggers active secretion of ASL by airway epithelia 
     To further test the possible role of active epithelial ASL secretion in response to HTS 
treatment, we tested pharmacological agents that block epithelial ASL production. If HTS 
triggers neuron-stimulated epithelial ASL secretion, one would expect to block the effect of 
HTS by blocking ion transport by epithelial cells. However, if the effect of HTS is entirely 
mediated by an osmotic effect, then an ion transport blocker treatment should have little effect. 
As most of the ASL in the upper airways (i.e. down to about the 10th bronchial generation, 
where airway lumen is ~1–2 mm in diameter) is produced by submucosal glands (Tos, 1966; 
Wine and Joo, 2004), we tested blockers known to abrogate gland secretions on HTS-triggered 
ASL production (Baraniuk et al., 1999; Wine and Joo, 2004): the CFTR blocker CFTRinh172, 
the Na+:K+:2Cl- cotransporter blocker bumetanide (100 µM) (Wine and Joo, 2004), and a Ca2+-
activated Cl- channel blocker niflumic acid (100 µM) (Wine and Joo, 2004), and in HCO3--free 
saline solution (Joo et al., 2002).   
     HTS treatment of preparations incubated in the CFTR inhibitor alone produced a higher 
level of ASL secretion compared with preparations incubated in the cocktail of blockers (i.e. 
CFTRinh172, bumetanide, and niflumic acid in HCO3--free bath), suggesting that HTS triggers 
active ASL production by the airway epithelia in a CFTR-independent manner (Fig. 4.3A). In 
contrast, there was no difference in ASL production by ITS-treated preparations incubated with 
CFTR inhibitor alone or the blocker cocktail (Fig. 4.3B), indicating that the blocker cocktail 
specifically blocks the effect of HTS treatment. These results suggest that the CF airway 
responds to HTS treatment by triggering active ASL secretion independent of CFTR, by the 
airway epithelia. To estimate the proportion of ASL produced by active ASL secretion by CF 
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epithelia, we incubated preparations in CFTRinh172, bumetanide, and niflumic acid in HCO3-
-free saline and treated them with HTS or ITS (Fig. 4.3C). Since these preparations are unable 
to produce ASL through epithelial secretion, the difference in ASL produced by HTS and ITS 
treated preparations must be driven by the osmotic effect alone generated by the hypertonic 
treatment. The results show that ~50% of the ASL produced by HTS treatment in CF 
preparations (i.e. incubated in CFTRinh172) is generated by active ASL secretion by airway 
epithelia.   
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Fig. 4.3. HTS treatments stimulate active ASL production by airway epithelia.  (A)  Treatment with the 
CFTR blocker CFTRinh172 (100 µM) reduced HTS-triggered ASL production. However, treatment with 
CFTRinh172, bumetanide (100 µM), and niflumic acid (100 µM) in HCO3--free saline solution bath reduced HTS-
triggered ASL production even further (HTS, n = 45 beads form 15 tracheas; HTS+172, n = 59 beads form 12 
tracheas; HTS+Bumet+NA+172+HCO3--free, n = 24 beads form 7 tracheas). (B) In ITS-treated preparations 
incubation with the ion transport blocker cocktail (CFTRinh172, bumetanide, and niflumic acid in HCO3--free 
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bath) has a similar effect as CFTRinh172 alone (ITS, n = 49 beads form 14 tracheas; ITS+172, n = 29 beads from 
8 tracheas; ITS+ Bumet+NA+172+HCO3--free, n = 18 beads form 7 tracheas). (C) Approximately 50% of the 
ASL produced by HTS in airways without CFTR function is the result of the osmotic effect. After blocking all 
ion transport with CFTRinh172, bumetanide, and niflumic acid in HCO3--free saline, HTS produced ~50% less 
ASL secretion than that produced by preparations incubated with CFTRinh172 alone (HTS+172, n = 59 beads 
form 12 tracheas; HTS+ Bumet+NA+172+HCO3--free, n = 24 beads form 7 tracheas; ITS+ 
Bumet+NA+172+HCO3--free, n = 18 beads form 7 tracheas). Data is presented and the statistical analyses were 
performed on an individual bead measured value basis. Data is presented as mean ± SEM and was analyzed by 
two-way ANOVA and Tukey’s multiple comparison test. The error bars are small and hidden behind the symbols. 
Data sets labeled with different letters differ significantly, p < 0.05. 
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4.5 Discussion 
     The key finding in this study is that HTS treatment triggers ASL production, not only 
through an osmotic effect that draws water from the serosal surface into the ASL, but also 
through the stimulation of the nervous system, which triggers active ASL secretion by airway 
epithelia. The presence of hypertonic saline may be detected by Aδ and C fibers (Pedersen et 
al., 1985; Fox et al., 1995), probably as a change in osmolality or ion concentration in the 
sensory neurons (Pedersen et al., 1985), which triggers the local release of neurotransmitters 
that stimulate ASL secretion from airway submucosal glands (Wine and Joo, 2004), and 
possibly modulates surface airway epithelia ion transport (Joo et al., 2016). Aδ and C fibers are 
more frequent in the larger airways (Chou et al., 2008), which may explain the recent 
unexpected finding that HTS treatment has a stronger effect on mucociliary clearance in the 
larger airways than in small ones (Cazzarolli et al., 2016).  
     The contribution of the nervous system to HTS-triggered ASL secretion may be larger in 
vivo, where the nervous system is intact and nebulization with HTS may trigger central reflexes 
and more vigorous epithelia secretion (Chou et al., 2008). A large number of nervous signals, 
including cholinergic, neurokinins, and vasoactive intestinal peptides may stimulate epithelial 
ASL secretion and also can have additive or synergistic effects (Widdicombe and Wine, 2015). 
In our ex vivo preparation, we detected substance P and cholinergic mediated stimulation of 
ASL secretion, however, only cholinergic stimulation had an effect on preparations without 
functional CFTR, suggesting that the contribution of the nervous system on HTS-triggered ASL 
secretion would be different in CF and in non-CF airways (Cazzarolli et al., 2016; Widdicombe 
and Wine, 2015). 
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     Our results also indicate that it may be possible to modulate the duration and intensity of 
HTS treatment by pharmacologically modulating the contribution of the nervous system to 
ASL secretion by using agonists, such as capsaicin, or by using blockers, such as lidocaine. 
Finally, our results highlight that the use of HTS formulations, which include blockers of 
epithelial ASL reabsorption (e.g. ENaC blockers) may reduce the effect of HTS treatment if 
they interfere with epithelial ASL secretion (Donaldson et al., 2006). 
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Chapter 5 
Ion transport anomalies by the collecting and ciliated ducts contribute to airway surface 
liquid secretion deficient by submucosal glands in cystic fibrosis swine 
 
5.1 Abstract 
     The upper airway is protected by an efficient innate defence mechanism that relies on the 
airway surface liquid (ASL) to trap, kill, and clear pathogens from the lungs. Most of the ASL 
required for host defence in the upper airway is secreted by submucosal glands. In CF, the 
function of airway submucosal glands is abnormal, resulting in the production of ASL with 
lower pH, reduced antimicrobial properties, and abnormal rheological properties. The glands’ 
abnormal function contributes to the failure of bacterial clearance from the lungs. This failure 
triggers a cycle of infection and inflammation that may eventually result in respiratory failure. 
These abnormalities are attributed to anomalies in ion transport across the epithelia lining the 
different section of the gland, each of which function coordinately to produce the ASL. 
However, the ion transport properties of each individual segment of the gland (i.e. serous acini, 
mucous tubules, collecting duct and ciliated duct) are unknown, and there is controversy 
regarding what segments express CFTR. This makes it difficult to determine the nature of 
glandular abnormalities that may contribute to CF lung disease and to identify targets for 
treatment. Using a self-referencing ion selective electrode technique, we characterized Cl- and 
Na+ transport properties in all four segments of the submucosal glands, and we identified how 
they are anomalous in CF swine. Our results show that in normal airway, the serous acini and 
collecting duct secreted Cl- and Na+ into the lumen in response to carbachol and forskolin 
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stimulation. The ciliated duct also transported Cl- and Na+ but in the opposite direction, i.e. 
reabsorption from the ASL, which may contribute to lowering Na+ and Cl- concentrations in 
the glandular secretion relative to the plasma. In CFTR-/- airway the serous acini, collecting 
duct, and ciliated duct fail to execute their function after forskolin stimulation, which results in 
abnormal ASL production with reduced pH but normal Cl-, Na+ and K+ concentration.  
 
5.2 Introduction 
     Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in 
the gene encoding the anion channel Cystic Fibrosis Transmembrane conductance Regulator 
(CFTR). Most of the morbidity and mortality suffered by CF patients arises from lung disease 
(Stoltz et al., 2015) that results from chronic bacterial infections and inflammation. However, 
the sequence of events that result in lung disease from CFTR mutations is not fully understood. 
Data accumulated over the last few years show that the first consequence of CFTR mutation is 
an impaired ability to eradicate bacteria from the lungs.  
     Lungs from CF animal models (F508del and CFTR-/- pigs) (Ostedgaard et al., 2011; 
Stoltz et al., 2010) fail to clear bacteria as effectively as wild-type littermates before the 
development of inflammation (Stoltz et al., 2010; Stoltz et al., 2013). This suggests that 
impaired bacterial elimination is the pathogenic event initiating a cascade of inflammation and 
pathology in CF lungs (Stoltz et al., 2010). Research in neonate animal models of CF suggest 
that the failure to clear bacteria may be the result of abnormal airway surface liquid (ASL) 
secretion by airway submucosal glands (Luan et al., 2014; Luan et al., 2017). The ASL 
produced by CFTR-/- swine has low pH and bacteria killing properties (Stoltz et al., 2010; 
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Pezzulo et al., 2012; Joo et al., 2006; Joo et al., 2010; Ballard et al., 2016). The ASL rheological 
properties of the ASL are also abnormal, causing ASL to be retained within the glands, which 
reduces the rate and efficiency of mucociliary clearance (Hoegger et al., 2014; Ballard et al., 
2016; Tang et al., 2016; Jayaraman et al., 2001; Roy et al., 2014). Thus, it has been proposed 
that abnormal ion transport by submucosal gland is the pathogenic event that inhibits the innate 
immune function of the airway, and triggers a cycle of infection and inflammation that may 
eventually lead to respiratory failure in CF patients (Joris et al., 1993; Smith et al., 1996; Choi 
et al., 2009; Wine and Joo, 2004, Widdicombe and Wine, 2015). Unfortunately, we have a poor 
understanding of how the properties of the ASL are regulated. We also do not understand the 
function(s) of the different cell types and anatomical regions of the gland. Thus, we do not 
know how they malfunction in CF.   
     Submucosal glands are complex organs comprised of four distinct segments – the serous 
acini, the mucous tubule, the collecting tube, and the ciliary duct (Meyrick et al., 1969), as 
shown in Fig. 5.1. The serous acini have been well studied and are known to be the primary 
site of fluid secretion (Mayerick and Reid, 1970). The fluid then flows into the mucous tubules 
and hydrates the gel-forming mucins secreted by mucus cells (Widdicombe and Wine, 2015; 
Wine and Joo, 2004). The mucous tubules feed into the collecting duct, and the fluid is then 
transported through the ciliated duct and released onto the airway surface. It is not known 
whether the duct cells contribute to ASL formation (Wine and Joo, 2004).  The anatomical 
characteristics of the duct cells as well as reports of CFTR expression in duct epithelia 
suggested that they may be involved in ion transport and modulation of ASL properties and 
may malfunction in CF (Meyrick et al., 1969; Englehardt et al., 1992; Wine and Joo, 2004; 
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Kedra et al., 2005; Jiang and Engelhardt, 1998). However, to date, there is no direct evidence 
of the ion transport properties of each segment of the gland. We thus do not how their functions 
are altered in CF. A key reason for this lacuna is the lack of a technique that has sufficient 
resolution to measure ion transport within each of the subunits of the submucosal gland. 
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Fig. 5.1 Segmentation model of airway submucosal gland. (adapted from Wu et al., 2007) 
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     In this study, we use a self-referencing ion selective microelectrode technique capable of 
spatial resolution unparalleled by previous studies, to measure the ion transport properties of 
the different segments of the airway submucosal glands in wild-type and in CFTR-/- swine.  
Our results show that stimulating wild-type airway submucosal glands with the intracellular 
cAMP elevating agent, forskolin, or the cholinergic agonist, carbachol, activated Na+ and Cl- 
transport by the serous acini, the collecting duct, and the ciliated duct. Quite interestingly, we 
found that the ciliated duct reabsorbs NaCl from the lumen of the gland, which may explain 
the reduced NaCl concentration in glandular secretion. In CFTR-/- swine glands, the serous 
acini, collecting duct, and ciliated duct fail to respond to forskolin stimulation, and the pH of 
glandular secretion was acidic. 
 
5.3 Materials and Method 
     All procedures were approved by the Animal Care Committee of the University of 
Saskatchewan. The full detail of experimental methods can be found in the supplemental 
methods section 
 
Tracheal preparation and dissection of submucosal glands 
     Swine airways and lungs were harvested from wild-type juvenile female and male pigs 
weighing 20-23 kg or one week old, and from CFTR-/- swine aged from 2-7 days. The trachea 
and major bronchi were dissected within 15-30 minutes of euthanasia and placed in ice cold 
Krebs–Ringer bicarbonate buffer (mmol l-1): 115 NaCl, 2.4 K2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 
1.2 MgCl2, 25 NaHCO3, 10 glucose (pH=7.4) equilibrated with 95% O2, 5% CO2. Since the 
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viability of the tissue declines with time we did not keep the tissue for more than 30h after 
euthanasia. To minimize tissue exposure to endogenously generated prostaglandins during 
tissue preparation, mounting, and experimentation, 1 µmol l-1 indomethacin was present in the 
bath throughout. 
     Dissected pieces of airway (~3 cm2) were pinned mucosal side up. The mucosa 
containing submucosal glands was dissected from the cartilage and pinned onto the petri dish 
with the serosal side up.  
 
Construction of ion-selective microelectrodes 
     The liquid membrane ion-selective microelectrodes were fabricated from borosilicate 
unfilamented capillary glass (WPI, Sarasota, USA). The capillary glass was washed for 10 min 
in nitric acid, then rinsed with deionized water and baked on a hot plate at 250°C for at least 
30 min. The capillaries were then removed from the hotplate and pulled on a vertical 
micropipette puller (PC-10, Narishige, Japan). The diameters of microelectrodes tip were about 
~5 μm. Retention of the hydrophobic ionophore cocktails requires salinization of the interior 
of the capillary. For this purpose, the capillaries were placed on a hot plate at 250 °C and cover 
by a glass petri dish with approximately 500 μl of dimethyldichlorosilane (Fluka), whose 
vapors salinize the interior of the capillary. The capillaries were baked for overnight at 250°C. 
Finally, a short column of liquid ion-selective cocktail of ~250 μm was introduced into the 
capillary and it was backfilled with the appropriate solution. 
     Sodium microelectrodes were made with Na+ Ionophore II-Cocktail A (Fluka) and 
backfilled with 100 mmol l-1 NaCl solution. These electrodes were calibrated using 15 mmol l-
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1 NaCl + 135 mmol l-1 LiCl and 150 mmol l-1 NaCl solutions. The change in voltage measure 
for a tenfold change in ion activities (i.e. slope) was 52.7 ± 0.2 mV.  
     Potassium microelectrodes were made with K+ Ionophore I-Cocktail B (Fluka) and 
backfilled with 100 mmol l-1 KCl solution. These electrodes were calibrated using 15 mmol l-
1 KCl + 135 mmol l-1 NaCl and 150 mmol l-1 KCl solutions. The change in voltage measured 
for a tenfold change in ion activities (i.e. slope) was 52.3 ± 0.6 mV.  
     Chloride microelectrodes were made with Cl- Ionophore I-Cocktail A (Fluka) and 
backfilled with 1 mol l-1 KCl solution. These electrodes were calibrated using 10 mmol l-1 KCl 
and 100 mmol l-1 KCl solutions. The change in voltage measure for a tenfold change in ion 
activities (i.e. slope) was 57.0 ± 0.6 mV.  
 
Measurement of ion flux 
     We used the Scanning Ion-selective Electrode Technique (SIET, Forestdale, MA, USA) 
and the automated scanning electrode technique (ASET 2.0) software (Science Wares Inc. East 
Falmouth, MA, USA) to measure ion flux across the different segments of submucosal glands. 
SIET permits non-invasive measurements of ion flux in isolated epithelia (Doughty and 
Langton, 2001; Smith and Trimarchi, 2001; Messerli et al., 2009) or in in-situ preparations 
(Boudko et al., 2001). The gland preparation was mounted in a temperature-controlled (37°C) 
custom-build chamber. The sites of interest (2 sites in each segment per gland) was identified 
and the electrode was programed to measure ion flux 3 times in each site. Thus, for each gland, 
we report the ion transport properties of a single region (e.g. serous acini) that is calculated as 
the average of 2 different sites and 3 repetitions per site.  
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     The electrode was repeatedly moved between two measuring points within the unstirred 
layer that were separated by 50 µm (determined as optimal in preliminary experiments) using 
computer-controlled stepper motors. After each movement the system waited for 3s to ensure 
that electrode movement did not disturb the unstirred layer before measuring the voltage for 
1s. The average of three repetitive measurements at each site was used to calculate the ion flux. 
The reference electrode was Ag/AgCl connected via a salt bridge (3 M KCl with 3% agar inside 
1.5 mm diameter borosilicate glass capillary) in a fixed place in the bath 30 to 50 mm away 
from the stepping ion selective microelectrodes. Baseline potential differences were 
established at locations in the bath 1.5 mm away from the specimen where there is no detectable 
unstirred layer. All measurements at the specimen are referred to baseline readings taken 
periodically during the experiment. 
     The voltage gradients obtained from the ASET software was used to calculate 
concentration gradients:  
∆C = 𝐶𝐶𝐵𝐵×10∆𝑉𝑉𝑆𝑆 − 𝐶𝐶𝐵𝐵 
     Where, ∆C, in µmol l-1 cm-3, is the concentration gradient between two points 50 μm 
apart. CB is the measured background ion concentration in µM. ∆V is the voltage gradient 
obtained from ASET in µV, and S is the slope of the microelectrode obtained from the 
calibration curve. The ion concentration gradient was then converted into ion flux using Fick’s 
law of diffusion: 
𝐽𝐽𝐼𝐼 = −𝐷𝐷𝐼𝐼(∆𝐶𝐶)∆𝑥𝑥 , 
     Where JI is the net flux of the ion in pmol cm-2 s-1. DI is the diffusion coefficient of the 
ion (1.55×10-5 cm2 s-1 for Na+ and Cl- and 1.92×10-5 cm2 s-1 for K+). ∆C is the concentration 
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gradient in pmol cm-3 and ∆x is the distance between the two points, 50 µm, expressed in cm. 
Negative values indicate that ions are moving into the lumen of the serous acini and positive 
flux value indicate that ions are moving from the lumen of the serous acini to the bath. 
     The experimental saline solution used for SIET experiments were modified from the 
normal Krebs solution to maximize the signal. For Na+ measurements, the bathing solution 
contained 50 mmol l-1 Na+ (mmol l-1): 25 NaCl, 2.4 K2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 1.2 MgCl2, 
25 NaHCO3, 10 glucose, 90 NMDG-Cl- (pH 7.4). For Cl- measurements, the bathing solution 
contained 65 mmol l-1 Cl- (mmol l-1): 65 NaCl, 2.4 K2HPO4, 0.4 KH2PO4, 1.2 Ca Gluconate, 
1.2 Mg Gluconate, 25 NaHCO3, 10 glucose, 50 Na Gluconate (pH 7.4). For K+ measurement, 
normal Krebs solution was used (see above). Isolated submucosal glands were placed in dishes 
with the different saline solutions for at least 15 minutes before starting measuring. All the 
experiments were performed around 36°C. 
     The detail procedure to measure the efficiency and spatial resolution of ion selective 
electrode is described elsewhere (Rheault and O’Donnell, 2001; Pineros et al., 1998; Somieski 
and Nagel, 2001). We used 1 M NaCl with 0.5% (w/v) agar with tip size about 5 µm as the 
artificial Na+ sources to determine the efficiency and space resolution of our SIET setup. 
     To determine the efficiency of the ion selective electrode, the ratio between the 
experimental and theoretical slopes of ion concentration change versus distance from the 
source are measured. As shown in Fig 5.2b and c, experimental measurements (open circles) 
were made by vibrating the microelectrode through an amplitude of 50 µm at each distance 
and theoretical values (filled circles) were calculated according to the following equation:  
ΔV=S[(-UΔr)/(CBr2+Ur)]/2.3 
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where ΔV is the change (mV) over the vibration excursion, S is the slope of the electrode, r is 
the distance from the source, Δr is the amplitude of the vibration, CB is the background activity 
of Na+ and U is an empirical constant.  
     To calculate the empirical constant U, a plot of ion activity values at different distances 
from ion source versus the inverse of the distance from the Na source (1/r) yields were 
measured, and the slope of the plot indicated the empirical constant U, as described in the 
following equation:  
C=CB+U/r 
where CB is the background activity of Na+.  
     The efficiency of our SIET Na+ flux measurement was 78%, which is consistent with 
previous reports the performance Na+ electrode. 
     To estimate the spatial resolution of our Na+ electrode, the ability to resolve two Na+ 
point sources was tested (Fig. 5.2d). Two Na+ sources were placed 35 µm apart, and the Na+ 
flux was measured at both point source and the space surrounding and between the sources 
every 5 µm per step (Fig. 5.2e). The data shows that SIET can easily resolve the two Na+ point 
sources, suggesting that the space resolution of our SIET system allow us to study different 
segments of airway submucosal gland.  
 
Secretion assay 
     We used the secretion assay developed by Quinton (1979) as explained elsewhere 
(Ianowski et al., 2007). Briefly, the mucosal layer from trachea or primary bronchus, with 
underlying glands, was dissected from the cartilage. A piece of tissue of about 1 cm2 was pinned 
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mucosal side up and mounted in a 35-mm-diameter plastic Petri dish lined with Sylgard (Dow 
Corning Corp). The serosal side was immersed in a bathing solution (~1 ml volume) and the 
mucosa was in air. Before experimentation, the mucosal surface was gently cleaned and blotted 
dry with cotton swabs and further dried with a stream of air, after which 20–30 μl of water-
saturated mineral oil was placed on the surface. The preparation was then placed in a 
temperature controlled chamber (TC-324B, Warner Instruments, Hamden, CT, USA) 
maintained at 37°C and equilibrated with warmed, humidified 95% O2 and 5% CO2. 
Pharmacological agents were diluted to final concentrations with warmed bath solution 
equilibrated with 95% O2 and 5% CO2. They were added to the serosal side by complete bath 
replacement.  
     Fluid secreted by individual submucosal glands formed droplets under oil. Images of the 
lumen of the trachea were taken at 2 min intervals using a digital camera (MiniVid, LW 
Scientific, Lawrenceville, GA, USA) and stored for off-line analysis. Stored images were 
analyzed using ImageJ 1.32J (NIH). Secretion volumes were calculated, as previously 
described, by assuming the mucus droplet to be spherical. Then V =4/3π r3, where r is the radius 
(Joo et al., 2001). The following inclusion criteria for individual droplets were used: (a) circular 
outline so that a spherical shape could be assumed; (b) clear edges to allow accurate 
measurement of the radius; and (c) no fusion with neighboring droplets. Viability of the 
preparation was tested at the end of each experiment by measuring the response to carbachol. 
Non-responding glands (<5%) were excluded from the analysis. The secretion rate was 
calculated by fitting the volume versus time plots using linear regression using at least 4 points 
and the slopes were taken as the secretion rates. The r2 value for such linear fits was > 0.8. 
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Reagents 
     CFTR Inhibitor-172 was obtained from Cedarlane Labs (Burlington, ON, CA); all other 
compounds were obtained from Sigma (St Louis, MO, US). The solution of carbachol was 
dissolved directly in Krebs solution. Stock solutions of CFTR Inhibitor-172 and forskolin were 
dissolved in DMSO and the final concentration of DMSO was less than 0.1%. 
 
Statistics 
     SIET ion flux data are presented as means ± SEM obtained from the average of three 
repeated measurements at the same site. Sample size (n) is the number of glands. The data were 
analyzed using ANOVA, with P < 0.05 considered significant. Data analysis was done using 
GraphPad prism 5 (GraphPad Software Inc., San Diego, CA, US). 
 
5.4 Results and Discussion 
     We studied the Na+ and Cl- transport properties of the different segments of the airway 
submucosal gland using the Scanning Ion-selective Electrode Technique (SIET, Fig. 5.2, see 
methods, Shipley and Feijó, 1999; Kunkel et al., 2006). SIET takes advantage of the ion 
concentration gradient generated by an ion transporting epithelium, i.e. the unstirred layer 
adjacent to the cells (Fig. 5.2a). The intensity of this unstirred layer is proportional to the 
epithelial transport rate (Barry and Diamond, 1984). Hence, it is possible to map and measure 
patterns of Na+ or Cl- flux across an epithelium by measuring the Na+ or Cl- concentration 
gradient in the unstirred layer. SIET uses a computer-controlled ion selective microelectrode 
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(ISE, Fig. 5.2a) positioned at two sites within the unstirred layer to measure the ion 
concentration gradient (Fig. 5.2b). We then use Fick’s law of diffusion to calculate the diffusion 
rate of the ions within the unstirred layer, which in steady state, matches net epithelial ion 
transport (Kuhtreiber and Jaffe, 1990). Thus, SIET directly measures ion (i.e. Na+, K+ and Cl-) 
transport rate regardless of the transport pathway (transcellular or paracellular) or whether it is 
passive or active. Another advantage of SIET is the remarkably high temporal and spatial 
resolution of the technique, which may be in the order of seconds and spatial resolution of ~10 
µm (Smith et al., 1999; Piñeros et al., 1998; Somieski and Nagel, 2001, see Methods). We 
tested the spatial resolution of our electrodes and sampling protocol using two point sources of 
NaCl separated by 35µm (Fig. 5.2d and e, Somiesk and Nagel, 2001, see methods) and showed 
that SIET easily resolved the two point sources, indicating sufficient spatial resolution to 
discriminate the different segments of the glands. 
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Fig. 5.2. SIET demonstration. a) Schematic diagram showing an ion selective electrode in an experimental setup. 
The electrode records the ion concentration difference between two points and calculates the ion flux across the 
epithelium. b and c) Experimental measurements (open circles) were made by vibrating the microelectrode 
through an amplitude of 50 µm at each distance. Theoretical values (filled circles) were calculated according to 
the following equation: ΔV=S[(-UΔr)/(CBr2+Ur)]/2.3, where ΔV is the change (mV) over the vibration excursion, 
S is the slope of the electrode, r is the distance from the source, Δr is the amplitude of the vibration, CB is the 
background activity of Na and U is an empirical constant. b shows the calculation of the empirical constant U. 
Static measurements were made at a series of distances from the source, and the millivolt outputs were then 
converted to activity values. A plot of these activity values versus the inverse of the distance from the Na source 
(1/r) yields a line with a slope of U, according to the equation: C=CB+U/r, where CB is the background activity of 
Na and U (mmolcm-2) defines the diffusion characteristics of the gradient source. Electrode efficiency (78 %) was 
calculated as the ratio of the slope of the experimental data to the slope of the theoretical data. d and e) the 
performance Na electrode in the vicinity of two Na souces about 35 µm apart. 
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Ion transport properties of the serous acini  
     We measured transepithelial flux of Na+, K+ and Cl- across the serous acini of 
submucosal glands from wild-type and CFTR-/- swine. At baseline conditions (i.e. without any 
treatment) serous acini from wild-type airway submucosal glands displayed little Na+, K+ and 
Cl- transport (Fig. 5.3a). However, treatment with forskolin (10 μM), an intracellular cAMP 
elevating agent that stimulates CFTR-dependent gland secretion, triggered serous acini 
epithelia to transport Na+ and Cl- ions from the bath into the lumen, i.e. generating negative 
values for Na+ and Cl- flux measurement (Fig. 5.3).  Serous acini preincubated with 
CFTRinh172 (100µM) - a CFTR anion channel blocker – failed to trigger forskolin-stimulated 
Na+ and Cl- flux (Fig. 5.3). On the other hand, stimulation with the cholinergic agonist 
carbachol (1µM), with or without CFTRinh172, triggered serous acini cells to move Na+ and 
Cl- ions from the basolateral bath into the apical lumen side at a rate similar to that observed 
after forskolin stimulation (Fig. 5.3a, b and f).   
     In contrast, K+ ion flux does not seem to contribute to fluid production since it remained 
unaltered and did not significantly differ from zero both before and after forskolin or carbachol 
treatment (data not shown). These data suggest that Na+ is the main cation involved in fluid 
secretion by serous cells. 
     We characterized the function of the serous acini in CF airway submucosal glands 
isolated from 2 to 7 days old CFTR-/- swine by measuring Na+ flux. These Na+ flux 
measurements are surrogates for NaCl and/or NaHCO3- transport across the epithelia since Na+ 
transport rate must be matched by a counter-ion (i.e. Cl- or HCO3-) to maintain electroneutrality. 
Thus, abnormal Cl- transport would also cause abnormal Na+ transport, which would be 
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detected by SIET. Our results show that baseline Na+ transport levels in CFTR-/- swine were 
unperturbed even after treating preparations with forskolin. This is consistent with what is 
expected when tissues lack functional CFTR channels. However, like wild-type glands, the 
CFTR-/- serous acini showed bath to lumen Na+ transport after carbachol treatment (Fig. 5.3e 
and h). Similar results have been reported previously using secretion assays (Joo et al., 2010). 
These data reinforce previous reports suggesting that the serous acini are the primary source of 
CFTR-mediated ASL secretion and their dysfunction contribute to CF pathogenesis. 
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Fig. 5.3. Cl- and Na+ fluxes across the serous acini measured by SIET in normal and CF swine tissue. a) 
Sample trace of Cl- flux across serous acini of wild-type tissue at baseline condition, Forskolin-treated (10 µM), 
and Carbachol-treated (1 μM) conditions. b)  Sample trace of Cl- flux across serous acini of wild-type tissue with 
CFTRinh172 (10 µM) at baseline condition, Forskolin-treated (10 µM), and Carbachol-treated (1 μM) conditions. 
c) Sample trace of Na+ flux across serous acini of wild-type tissue after different treatments. d) Sample trace of 
Na+ flux across serous acini of wild-type tissue with CFTRinh172 (10 µM) after different treatments. e) Sample 
trace of Na+ flux across CFTR-/- serous acini. f) Summary of Cl- flux changes across serous acini during baseline 
condition, Forskolin, Forskolin + CFTRinh172, Carbachol, and Carbachol + CFTRinh172 in wild-type tissue (n 
= 13 glands from 6 animals for baseline, Forskolin, and Carbachol, and n = 11 glands from 6 animals for 
Forskolin+172 and Carbachol+172). g) Summary of Na+ flux changes across serous acini during baseline 
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condition, Forskolin, Forskolin + CFTRinh172, Carbachol, and Carbachol + CFTRinh172 in wild-type tissue (n 
= 16 glands from 7 animals for baseline, Forskolin, and Carbachol, and n = 12 glands from 7 animals for 
Forskolin+172 and Carbachol+172). h) Summary of Na+ flux changes across serous acini during baseline 
condition, Forskolin, and Carbachol in CFTR-/- tissue (n = 10 glands from 7 animals for baseline, Forskolin, and 
Carbachol). The statistical analyses were performed on an individual gland measured value basis. (Different letters 
indicate statistical difference, p<0.05, one way ANOVA, Student-Newman-Keuls multiple comparison test). 
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Ion transport properties of the mucus tubule 
     The mucous tubules showed low Na+ and Cl- movement at baseline conditions and were 
not increased by forskolin simulation. However, the mucous tubule responded to cholinergic 
stimulation (carbachol 1µM) by triggering Na+ and Cl- fluxes from the basolateral side to the 
apical side, thus contributing to ASL secretion (Fig. 5.4a and d).  
     In the presence of CFTRinh172, the mucous tubule segment did not behave any 
differently, suggesting that this response is independent of CFTR. Furthermore, the mucous 
tubules from CFTR-/- swine showed the same ion transport pattern as that of wild type swine 
(Fig. 5.4b and c). This is consistent with the finding that mucous tubules do not seem to express 
CFTR protein (Engelhardt et. al., 1992; Jiang and Engelhardt, 1998). To our knowledge, this is 
the first evidence that mucous tubule, in addition to secreting mucins (Finkbeiner et al., 2011), 
may also contribute ions and fluid transport to the ASL produced by airway submucosal 
glandular, after cholinergic stimulation.  
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Fig. 5.4. Cl- and Na+ fluxes across the mucous tubule measured in normal and CF swine tissue. a) 
Measurements of Cl- fluxes across mucous tubule during different treatments (untreated baseline, Forskolin, 
Forskolin + CFTRinh172, Carbachol, and Carbachol + CFTRinh172) in wild-type gland (n = 10 glands from 6 
animals for baseline, Forskolin, and Carbachol, and n = 8 glands from 6 animals for Forskolin+172 and 
Carbachol+172). b) Measurements of Na+ fluxes across mucous tubule during different treatments (untreated 
baseline, Forskolin, Forskolin + CFTRinh172, Carbachol, and Carbachol + CFTRinh172) in wild-type gland (n = 
11 glands from 7 animals for baseline, Forskolin, and Carbachol, and n = 8 glands from 6 animals for 
Forskolin+172 and Carbachol+172). c) Measurements of Na+ fluxes across mucous tubule during different 
treatments (untreated baseline, Forskolin, and Carbachol) in CFTR-/- gland (n = 8 glands from 6 animals for 
baseline, Forskolin, and Carbachol). The statistical analyses were performed on an individual gland measured 
value basis. (Different letters indicate statistical difference, p<0.05, one way ANOVA, Student-Newman-Keuls 
multiple comparison test). 
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Ion transport properties of the collecting duct 
     The collecting duct cells displayed a basal level of Na+ and Cl- transport that was not 
different than 0 flux (Fig. 5.5). Upon stimulation with forskolin both Cl- and Na+ increased 
transepithelial flux from the bath into the lumen, contributing to ASL production. Treatment 
with the CFTR inhibitor, CFTRinh172 (100µM), blocked the effect of forskolin on Na+ and Cl- 
transport, suggesting that it is CFTR dependent. On the other hand, carbachol (1 μM) 
stimulated Na+ and Cl- ions transport into the lumen of the collecting duct from the surrounding 
saline bath, and this response was not affected by CFTRinh172 (Fig. 5.5a and b).  
     In CFTR-/- swine airway submucosal glands, the collecting duct did not respond to 
forskolin stimulation, but increased Na+ flux after carbachol treatment (Fig. 5.5c). These results 
are the first direct evidence that the collecting duct contributes to production of ASL and their 
function is abnormal in CF. 
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Fig. 5.5. Cl- and Na+ fluxes across the collecting duct under different stimulations in normal and CF swine 
tissue. a) Changes of Cl- flux across collecting duct during baseline condition, Forskolin-challenge, Forskolin + 
CFTRinh172- challenge, Carbachol-challenge, and Carbachol + CFTRinh172-challenge in wild-type gland (n = 
8 glands from 5 animals for baseline, Forskolin, and Carbachol, and n = 7 glands from 5 animals for Forskolin+172 
and Carbachol+172). b) Changes of Na+ flux across collecting duct during baseline condition, Forskolin-challenge, 
Forskolin + CFTRinh172- challenge, Carbachol-challenge, and Carbachol + CFTRinh172-challenge in wild-type 
gland (n = 11 glands from 7 animals for baseline, Forskolin, and Carbachol, and n = 7 glands from 4 animals for 
Forskolin+172 and Carbachol+172). c) Changes of Na+ flux across collecting duct during baseline condition, 
Forskolin-challenge, Carbachol-challenge in CFTR-/-gland (n = 7 glands from 5 animals for baseline, Forskolin, 
and Carbachol). The statistical analyses were performed on an individual gland measured value basis. (Different 
letters indicate statistical difference, p<0.05, one way ANOVA, Student-Newman-Keuls multiple comparison test). 
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Ion transport properties of the ciliated duct 
     Like the collecting duct, the ciliated duct epithelia did not have a basal ion transport level. 
After forskolin stimulation, the ciliated duct cells increased Na+ and Cl- transport, but 
interestingly, transport occurred in the opposite direction than what is observed in the serous 
acini, mucus tubule and collecting duct cells. The cells lining the ciliated duct transported Na+ 
and Cl- from the lumen of the glands back into the blood side of the tissue, i.e. removing ions 
form the ASL. Thus, depending the water permeability of this epithelium, the ciliated duct may 
either reduce the volume of ASL (high water permeability) or reduce the ion strength and 
osmotic pressure of the ASL (low water permeability). The effect of forskolin was blocked by 
incubation with the CFTR blocker, CFTRinh172, indicating CFTR-dependent ion transport in 
ciliated ducts (Fig. 5.6a and b).  
     Cholinergic stimulation of gland function triggered the ciliated ducts to transport Na+ 
and Cl- from the lumen into the bath, removing ions from the ASL (Fig. 5.6). This transport 
was not affected by blocking CFTR (Fig. 5.6). These are the first results directly demonstrating 
that the ciliated duct epithelium is involved in ASL formation, and is concordant with the 
finding that like airway surface epithelial cells, the ciliated ducts also express CFTR channels 
(Engelhardt et al., 1992; Kedra et al., 2005).  
     The ciliated ducts from CFTR-/- swine glands failed to respond to forskolin stimulation 
(Fig. 5.6c). However, the response to carbachol was similar to that observed in wild-type 
preparations. Thus, supporting the idea that in CF airway the ciliated epithelium would 
malfunction.   
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Fig. 5.6. Cl- and Na+ fluxes across the ciliated duct under different stimulations in normal and CF swine 
tissue. a) Summary of Cl- flux changes across ciliated duct during baseline condition, Forskolin-treatment, 
Forskoline + CFTRinh172-treatment, Carbachol-treatment, and Carbachol +CFTRinh172-treatment in wild-type 
gland (n = 9 glands from 6 animals for baseline, Forskolin, and Carbachol, and n = 7 glands from 5 animals for 
Forskolin+172 and Carbachol+172).  b) Summary of Na+ flux changes across ciliated duct during baseline 
condition, Forskolin-treatment, Forskoline + CFTRinh172-treatment, Carbachol-treatment, and Carbachol 
+CFTRinh172-treatment in wild-type gland (n = 10 glands from 6 animals for baseline, Forskolin, and Carbachol, 
and n = 7 glands from 4 animals for Forskolin+172 and Carbachol+172). c) Summary of Na+ flux changes across 
ciliated duct during baseline condition, Forskolin-treatment, and Carbachol-treatment in CFTR-/- gland (n = 7 
glands from 5 animals for baseline, Forskolin, and Carbachol). The statistical analyses were performed on an 
individual gland measured value basis. (Different letters indicate statistical difference, p<0.05, one way ANOVA, 
Student-Newman-Keuls multiple comparison test). 
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Ion composition of wild-type and CFTR-/- submucosal gland secretions 
     To further study the role of CFTR and the effect of CFTR mutation on ASL secretion, 
we measured pH and Na+, K+, and Cl- concentrations in secretions from individual airway 
submucosal glands. We collected secretions from individual glands using secretion assays in 
order to avoid potential alteration of fluid by airway surface epithelium. We then measured the 
ion composition using ion-selective microelectrodes.  The concentrations of Na+, K+ and Cl- 
were the same in basal, forskolin-stimulated, and carbachol-stimulated secretions. Interestingly 
the ion concentrations in the ASL was significantly lower than that of the fluid bathing the 
glands, thus suggesting that the ASL is hyposmotic with respect to the plasma (Table 5.1). This 
may be the result of ion reabsorption by the ciliated duct. Preincubation with the CFTR blocker, 
CFTRinh172, reduced the volume of ASL but had no effect in the Na+, K+, and Cl- 
concentrations of the ASL in basal, forskolin-stimulated and carbachol-stimulated compared to 
untreated control glands (Table 5.1, Jayaraman et al., 2001).   
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Table 5.1 Na+, Cl-, and K+ concentrations in the gland secretion bubble in health and CFTRinh172-treated 
pig tissue 
 
(Data is presented as mean ± SEM and the statistical analyses were performed on an individual gland measured 
value basis. Different letters in the same row indicate statistical difference, p<0.05, one way ANOVA, Student-
Newman-Keuls multiple comparison test). 
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     We also measured the pH in the glandular secretion under basal, forskolin-stimulated, 
and carbachol-stimulated conditions. We found ASL pH was 7.69 ± 0.05 and 7.72 ± 0.06 for 
basal and forskolin-stimulated glands, respectively, was not statistically different (p>0.05, n= 
9 secretion essay preparations for baseline and n= 9 secretion essay preparations for forskolin, 
two-way ANOVA). However, after stimulation with carbachol the pH of glandular secretion 
increased to 8.25±0.08 (p<0.05, n= 10 secretion essay preparations two-way ANOVA, Tukey’s 
multiple comparison test, Table 5.2). Treating the preparations with the CFTR inhibitor, 
CFTRinh172, significantly change the pH of the ASL secretion compared to untreated control 
glands (p<0.05, n= 5 secretion essay preparations for all baseline, forskolin, and carbachol, 
two-way ANOVA, Tukey’s multiple comparison test, Table 5.2). Accordingly, the ASL 
produced by glands from CFTR-/- swine had a more acidic ASL at all basal secretion, after 
stimulation with forskolin, as well as after stimulation with carbachol (p<0.05, n= 6 secretion 
essay preparations for all baseline, forskolin, and carbachol, two-way ANOVA, Tukey’s 
multiple comparison test, Table 5.2). This result is consistent with previous of low pH in ASL 
secretion by CFTR-/- glands (Pezzulo et al., 2012). 
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Table 5.2 pH measurements in health, CFTRinh172-treated, and CFTR-/- swine gland secretion 
 
(Data is presented as mean ± SEM and the statistical analyses were performed on an individual gland measured 
value basis. Different letters in the same row indicate statistical difference, p<0.05, one way ANOVA, Student-
Newman-Keuls multiple comparison test). 
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5.5 Conclusion 
     Most exocrine glands, such as submucosal glands, work in a similar fashion. A group of 
cells located at the distal most segment of the gland, produce a primary fluid that is later 
modified by the epithelia lining the tubular segments connected to the opening of the gland to 
produce secretion with varied properties, such as different pH, ion composition, protein content, 
etc (Humphrey and Williamson, 2001; Delporte, 2014; Quinton, 2007; Saga, 2002; Dartt, 2009). 
To understand how the airway submucosal glands determine the properties of the ASL and why 
they are abnormal in CF, we need to understand the function of each segment of the gland in 
health and disease. Our study is the first to directly measure ion transport properties across the 
different segments of the airway submucosal gland. The key finding is that in addition to the 
serous acini, the mucus tubule, collecting duct, and ciliated duct segments of the submucosal 
gland trigger ion transport after stimulation, and thus, may contribute to determining the ASL 
properties, e.g. pH, and rheological properties. Moreover, these segments malfunction in CF 
airway, which may contribute to the abnormal properties of the ASL in CF.  
The ion transport properties of the serous acini indicate the existence of CFTR-dependent and 
CFTR-independent ion transport pathways, which is consistent with previous publications 
(Widdicombe and Wine, 2015). A novel finding is that both pathways display very similar Na+, 
Cl-, and K+ transport, suggesting that both pathways produce fluid with similar ion composition. 
The fluid then enters the mucous tubules, which is believed to be mostly involved in mucin 
secretion (Audie et al., 1993; Aust et al., 1997; Widdicombe and Wine, 2015). One of the most 
unexpected results was the discovery that cholinergic stimulation, but not forskolin, triggers 
Na+ and Cl- transport from the bath into the gland lumen across the mucous tubules in both 
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wild-type and CFTR-/- preparation. These results indicate that the mucous tubule may 
contribute to the properties of the ASL by modulating the ion composition and volume of the 
ASL, in addition to producing mucin. 
     We also present the first ever evidence that the collecting and ciliated ducts are involved 
in ion transport as suggested by their anatomical characteristics and CFTR expression patterns 
in the epithelia cells of these segments (Kreda et al., 2005). Like the serous acini, the collecting 
duct transported Na+ and Cl- from the basolateral side (blood side) into the lumen of the gland, 
after stimulation with forskolin or carbachol. Since the cells lining the collecting duct express 
aquaporins (Kreda et al., 2001), the accumulation of NaCl in the lumen after stimulation of ion 
transport would drive water into the lumen, thus contributing to the volume and properties of 
the ASL secreted by the glands. In CFTR/airways, the forskolin-stimulated transport was absent, 
but cholinergic-stimulated transport was no different than wild-type., thus suggesting that the 
cAMP-mediated ion flux is dependent on CFTR and would be absent in CF. This indicates that 
abnormal collecting duct function may contribute to the abnormalities in ASL secretion in CF.  
     The ciliated duct also transports Na+ and Cl-, however, it does so in the opposite direction 
relative to the collecting duct, mucus tubule, and serous cells. The ciliated duct reabsorbs Na+ 
and Cl- from the lumen of the glands into the blood side. This transport may have two possible 
consequences, reducing the volume of ASL, or reduction of the Na+ and Cl- concentration of 
the ASL depending on the water permeability of the epithelia. The ion concentration 
measurements in the ASL excreted by glands (Table 5.1) show that the ASL has lower Na+, K+ 
and Cl- concentration than the bathing solution. These results support the view that the ciliated 
duct reduces the ion concentration of the primary fluid produced by the upstream segments of 
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the gland.  
     The concentrations of Na+, K+ and Cl- in the ASL were the same in all conditions, but 
the pH is significantly more acidic after forskolin stimulation compared to cholinergic 
stimulation in wild-type swine, suggesting that the regulation of pH may be different in these 
two stimulatory pathways (i.e. cholinergic vs. cAMP-dependent). Consistent with previous 
reports (Pezzulo et al., 2012), CFTR-/- swine produced acidic ASL. Treating wild-type glands 
with the CFTR blocker, CFTRinh172, resulted in secretion of a similarly acidic ASL, which is 
consistent with the hypothesis that acidic pH results from reduced HCO3- transport though 
CFTR. However, our data does not allow us to pinpoint which segment of the gland is 
responsible for the acidic pH.  
     Our results shed new light on the malfunction of the submucosal glands in CF. 
Dysfunctional CFTR channels would result in loss of cAMP-activated ion transport not only 
at the serous acini but also at the collecting duct, and ciliated duct. The resulting ASL has 
reduced volume and low pH. This may result in inadequate unpacking and hydration of mucins 
released by the mucus tubule. In addition, we show that basal and forskolin-stimulated ASL 
has low pH compared to cholinergic-stimulated ASL secretion, which suggests that CFTR-
dependent and CFTR-independent ASL secretion may have different properties and functions. 
In addition, the pH of the ASL from CFTR-/- swine display lower pH compared to wild-type. 
Overall, our study suggests that loss of CFTR-dependent ion transport leads to reduced 
glandular ASL secretion, and results in lower ASL pH. The abnormal ASL properties may 
contribute to the failure of the airway defense against pathogens. 
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Appendix A 
Using synchrotron-based phase contrast imaging to study early stage cystic fibrosis lung 
disease  
 
A.1 Abstract 
     Evidence show that children with CF may develop structural damage in small airway at 
early stage of life. Moreover, studies on the recently developed CF swine model shows that 
newborn piglets display distal airway lesions without any obvious evidence of airway infection 
or inflammation, which suggests that the CF lung disease starts in the small airway. 
Unfortunately, conventional imaging methods, such as hospital computed tomography (CT) 
scan and magnetic resonance imaging (MRI), are unable to visualize small airway about 1mm 
in cross section making difficult to study early CF lung disease. We developed a new high-
resolution imaging method to investigate early CF lung disease in the distal airway and to 
perform longitudinal studies to follow its progression. Our goal is to use synchrotron-based 
phase contrast CT to study the progression of the lung disease in vivo using CFTR-/- swine as 
CF model. Our experiments indicated that synchrotron-based phase contrast imaging CT scan 
allow us to visualize and investigate the distal airways in live swine. The combination of high 
energy monochromatic x-ray (70 keV), respiratory monitoring and gating system, and high-
speed Fiber Optic x-ray camera allow us to perform CT scan in live swine at the desired point 
of the respiratory cycle (fully inflated lungs), with high resolution and low radiation dose. Our 
data indicates that we can observe distal airways with 100 µm in diameter. 
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A.2 Introduction 
     Cystic fibrosis (CF) is the most common fatal genetic disease affecting Caucasian 
populations. Most of the mortality arises from lung disease. Unfortunately, the events leading 
from gene mutation to lung disease are not fully understood, and there is controversy regarding 
the primary defect responsible for CF airway disease pathogenesis.  
     Until recently, there was consensus in the field that blockage of air flow in the airway of 
CF patients resulted from repeated cycles of infection and inflammation, which trigger airway 
remodeling and mucus accumulation that damaged airway (Ramsey et al., 2012; Baltimore et 
al., 1989; Hamutcu et al., 2002). However, recent studies showed that CF infants and newborn 
CF piglet suffer from lesions that appear as regions with obstructed airflow, in the distal 
airways, without any obvious evidence of airway infection or inflammation (Sly et al., 2009; 
Hall et al., 2011; Adam et al., 2013). These observations indicate that lesions may be 
independent of infection/inflammation cycle. Thus, the results raise questions about the nature 
of CF small airway lesions: whether the small airway obstruction caused by liquid infiltration 
due to inflammation and/or by mucus plug that blocking air flow.  
     The major difficulty for investigating the CF distal airway pathogenesis is the lack of an 
imaging method with sufficient resolution to observe the distal airway in vivo. Current imaging 
methods (such as CT and MRI) are unable to resolve small airway (~ 1millimeter diameter) 
and it is not possible to observe anything smaller than mainstem bronchi in piglets in vivo 
(Adam et al, 2013). In addition, it is difficult to determine if the lesions are filled with fluid (i.e. 
a sign of inflammation) or air (a sign of mechanical blockage with mucus or tissue). Therefore, 
we have developed a new imaging technique to investigate the relation between structural 
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changes and physiologic abnormalities observed in the distal airways of CF lungs (i.e. CFTR-
/- swine) in vivo. We use synchrotron-based phase contrast imaging (PCI) to image the 
air/fluid/soft tissue interface in the lung and observe small airways. The large differences in 
refractive index between air, fluid, and soft tissue results in a strong refraction signature that is 
easily detected using phase-related imaging methods. We developed a new imaging method to 
visualize the small airway (~100 micrometer in diameter) and the content of the lesions in 
swine in vivo.  
 
A.3 Materials and Methods 
     One week old wild-type piglets, weighing about 3 kg, were purchased from Prairie Swine 
Centre. 
 
Synchrotron-based x-ray imaging set-up 
     Experiments were performed using the BioMedical Imaging and Therapy-Insertion 
Device (BMIT-ID) beamline 05ID-2, at the Canadian Light Source (CLS), Saskatchewan, 
Canada. The sample stage is located 58 meters away from the storage ring. Phase contrast 
imaging (PCI) was performed using monochromatic 70 keV (λ=0.018 nm) x-rays, selected 
using a standard double-crystal monochromator. The beam size was 200.0 mm (wide) x 8.0 
mm (vertical). The distance between the sample and the detector was 200 cm. Images were 
captured by using Photonic Science Fiber Optic Camera X-ray SCMOS. The converter on 
camera used a 15 μm-thick scintillator (Gd2O2S:Tb) to convert x-rays to visible light. The 
pixel size of the image was 25.3 x 25.3 μm. Exposure time per image during CT scan was 25 
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ms.  
 
Experimental set-up 
     One week old piglets were placed in a holder in an upright position. The animal was 
placed under anesthesia using 2-2.5% isoflurane. During the CT scan the custom-build animal 
holder limited the movement of the animal while allowing the pig to breath spontaneously 
throughout the experiment. Respiratory rate, heart rate, body temperature, and O2 saturation 
level as well as the plane of anesthesia were monitored during the imaging process. A m2m 
BioVet system was used to monitor the respiratory movements of the animas by attaching the 
sensors to the lower abdomen. The system also monitored the cardiac function and produced 
an electrocardiogram (ECG). The BioVet system controlled the gating of the imaging by 
triggering the shutter of the beam based on both respiratory cycle and ECG signals. The gating 
process reduces the unnecessary x-ray exposure time for the piglets, which would lead to the 
lower radiation dose for the animal, and minimizes movement artifacts. We used a 600-
projection CT scan protocol where the stage rotated 0.3 degree per step and the whole stage 
rotated 180 degrees in total. 
 
Data analysis 
     CT scan data was processed by image J, CT reconstruction was done by NRECON and 
Avizo. 
 
Study approval 
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     All experiments were performed with the approval of the Canadian Light Source and the 
Animal Ethics Committee at the University of Saskatchewan. 
 
A.4 Results and Discussion 
     Canadian Light Source BioMedical Imaging and Therapy (BMIT) Beamline provides a 
unique opportunity for our project. High energy x-ray generated by synchrotron source 
provides the ability of imaging large animals, such as swine, and high-resolution detector 
provide the ability to study the small airway, which are about 100 µm in diameter. High energy 
monochromatic x-ray (70 keV) was selected since the higher the x-ray energy, the lower the 
radiation dose delivered to the animal. Also, in order to provide a better signal-to-noise ratio, 
the sample to detector distance had been carefully chosen to highlight the distal airways but to 
avoid detecting the alveolus. To limit the radiation dose for the animal, we tightly control the 
exposure time and the number of projections during image acquisition for the CT scan. Our 
preliminary data shows that we can detect the small airways (less than 100 um in diameter) in 
piglets (Fig. A.1) with 600 projections CT scan and 25 ms exposure time, and the x-ray 
radiation dose for the one week old live piglet is ~400 mGy. Also, in order to test the functional 
imaging capabilities of the PCI CT, we mimic the condition of mucus plugging in the pig lung 
by injecting mucus in the lower bronchial of pig lung. In Fig. A.2, the presence of fluid in the 
small airway can be detected easily detected by PCI CT.  
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Fig. A.1. Re-sliced phase contrast CT lung image from ex vivo piglet scan acquired at ID beamline. The 
pixel size was 26 µm. Small airways (80 µm diameter) can be detected as indicated by red arrow. (Adapted from 
Wysokinski et al., 2016). 
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Fig. A.2. Ex vivo imaging of the small airway in a piglet. Left: un-treated lung, small airways (diameter = 100 
µm) are visible, as indicated by the red arrow. A larger distal airway (600 µm in diameter) is indicated by the 
yellow arrow. Right: after an obstruction (mucus) is introduced into the airway (yellow arrow), the airway 
disappears in the image. (Adapted from Wysokinski et al., 2016). 
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     To make sure we image the swine lung at the same respiratory state in each projection 
(at the end of inspiration), we use a respiratory monitoring and gating system (m2m BioVet 
system) to sense the respiratory cycle of the animal and trigger the shutter of the beam at the 
desired point in the cycle. By using the BioVet to control the image gating at BMIT-ID line, we 
can successfully image swine lungs in vivo. As shown Fig. A.3., distal airways with larger than 
200 µm in diameter can be easily detected by synchrotron-based PCI CT. And using 
reconstruction software, the respiratory tree in this swine lung can be mapped (Fig. A.4.).  
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Fig. A.3. In vivo imaging of a 7-day old swine. Re-sliced phase contrast CT pig lung image while using BioVet 
system to monitor and gate the imaging process. The white bar indicated 2 mm.  
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Fig. A.4. Avizo reconstruction of swine lung in vivo. The distal airways in the respiratory tree can be tracked in 
this swine lung. The white bar indicated 2 mm. 
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     Our results suggest that PCI CT would allow us to image small airways in vivo, as well 
as determine the presence of fluid, thus allowing us to test our hypothesis. In the future, we 
will compare the small airway anatomy for both wild-type and CF swine. Our ultimate goal is 
to investigate the changes in airway anatomy and the development and content (i.e. air vs liquid) 
of lesions in early disease in vivo in CF swine. We will try to follow the progression of the 
disease over time as the CF animals develop infection and inflammatory (within weeks after 
birth) and to correlate these findings with lung function using force oscillation technique, 
pathology studies, and electrophysiology techniques available in our lab to study the 
progression of CF lung disease. 
     This synchrotron-based PCI CT for the small airway promises to be a major 
breakthrough in the CF research field. We hope to be able to determine the early changes 
suffered by CF airways and produce a more in-depth description of the early CF airway disease. 
The knowledge acquired though this project will help identify novel treatment for CF airway 
disease patients. 
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Chapter 6 
General Discussion 
 
     This dissertation outlined the development of a novel imaging technique for studying the 
production of airways surface liquid in vivo in wild-type and CFTR-/- swine. We tested the 
effect of inhaled bacteria and hypertonic saline nebulization on liquid secretion in the upper 
airway of swine in vivo. We described the abnormal function of airway submucosal gland liquid 
secretion and its possible role in CF airway disease. We also described the function of the gland 
in health and disease.  
 
6.1 Major findings 
     1) The development of the synchrotron-based phase contrast imaging allows the study 
of ASL secretion in the upper airway of a living swine for the first time. 
     2) The discovery of bacteria-triggered, CFTR-dependent ASL secretion as part of the 
normal innate immune response to inhaled bacteria. CFTR is required for normal fluid 
secretion, which washes mucins and antimicrobial compounds from the submucosal glands 
into the airway lumen.  
     3) The bacteria-triggered ASL secretion fails in CFTR-/- swine, which would facilitate 
chronic infection and inflammation. 
     4) A basal level of CFTR-dependent ASL secretion is present in the trachea of live swine 
which perhaps contributes to ensure the minimal amount of ASL required for the background 
protection through mucociliary clearance. For example, protection against non-pathogenic 
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particles which, in contrast to pathogenic bacteria, do not trigger ASL secretion. 
     5) The basal ASL secretion by submucosal glands fails in CFTR-/- swine, predisposing 
the airways to infection. 
     6) Hypertonic saline nebulization, a standard treatment to rehydrate CF patients’ airway, 
does not only depend on osmotically driven fluid production but also relies on the neuron-
mediated ASL secretion from airway epithelium. 
     7) The Na+ and Cl- transport in serous acini, collecting duct, and ciliated duct regions of 
airway submucosal gland contribute to ASL production and secretion, and these functions are 
missing in CFTR-/- swine glands. 
     8) The synchrotron-based phase contrast CT we developed would be a useful tool to 
study the pathogenesis of CF lung disease specifically in the distal airway. 
 
6.2 Contribution to the field of CF research 
     My work is the first to describe the two CFTR-dependent ASL secretion mechanisms 
that contribute to the normal innate immune system: a bacteria-triggered, and a basal 
spontaneous ASL secretion in the upper airway in vivo. This work provides a better 
understanding of the airways innate immune response to inhaled pathogens, and why CF 
airway have a deficient innate immune defence system. 
 
6.2.1 Innate immune response to inhaled bacteria 
     My experiments showed that P. aeruginosa-triggered ASL is mediated by the activation 
of TLR5 on the airway surface epithelium, which in turn stimulates ASL secretion from airway 
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submucosal glands. Moreover, two other bacteria commonly found in CF patients, S. aureus 
and H. influenzae, neither of which express flagellin, stimulated CFTR-dependent ASL 
secretion, possibly via stimulation of TLR4 receptors by the endotoxin, lipopolysaccharide. On 
the other hand, non-pathogenic bacteria, E. coli DH5-α and B. subtilis did not trigger significant 
amount of ASL secretion in the airway. The results indicate that pathogen-triggered ASL 
secretion via PRRs, especially TLRs, is an important and previously unknown component of 
the airway innate immune defense system to against bacteria (Basu and Fenton, 2004; Mayer 
and Dalpke, 2007).  
     Furthermore, my results showed that non-pathogenic bacteria seem not to trigger ASL-
related innate immune response, which may be an important aspect of the respiratory 
microbiome formation. The lung has been previously thought to be sterile. However, since the 
development of non-culture dependent techniques to detect bacteria, evidence suggests that the 
respiratory system contains, similarly to the gut, a microbiome in healthy humans (Charlson et 
al., 2015; Bassis et al., 2015). Moreover, the lung microbiome seems to have a critical role in 
the development of a healthy immune system, and evidence suggests that dysbiosis of lung 
microbiome is involved in the development of chronic pulmonary disease, including CF 
(Shukla et al., 2017). A primary requisite for commensal or symbiotic bacteria to survive in the 
airway, and to form the microbiome, is that the innate immune system would not destroy it. 
Our discovery that some bacteria (i.e. non-pathogenic) do not trigger the innate immune 
response provides evidence that the lung would normally select against pathogenic bacteria 
and in favor of commensal or symbiotic microbes, thus providing a pathway for the 
development of a respiratory microbiome (Dickson and Huffnagle, 2015).  
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     Our experiments using CFTR-/- swine showed that the ASL secretion response to inhaled 
bacteria is missing. This is the first study to show direct relation between ASL secretion and 
inhaled bacteria in vivo, and the absence of ASL secretion in CF airway. The lack of ASL with 
antimicrobial factors would result in the failure of bacteria eradication in CF patients. Thus, 
the bacteria would tend to survive longer in airway which might favor infection and biofilm 
formation (especially from P. aeruginosa). This would lead to chronic infection and 
inflammation, which may eventually result in respiratory failure in CF patients. This missing 
innate immune defense response to inhaled pathogenic bacteria might to be the first step of 
developing of CF lung disease. Moreover, there may be consequences for the microbiome, 
since the selection pressure imposed by the innate immune system on pathogen secretion would 
be absent. Whether the microbiome is abnormal in CF and whether there is a pathological 
consequence due to an ‘abnormal’ microbiome is unknown. 
 
6.2.2 Role of the basal spontaneous ASL secretion on airway defense 
     It has been proposed for a long time that there may be a basal level of ASL production 
in the airways (Wine, 2007). However, due to the lack of a technique to study ASL secretion in 
vivo, this hypothesis was never tested. This study provides the first demonstration and 
investigation of the proposed basal spontaneous ASL secretion. This could only be performed 
in vivo, since only in this condition, are all the regulatory mechanisms intact (i.e. nervous, 
humoral, paracrine and circulatory systems). Thus, we used our synchrotron imaging method 
to study the possible basal ASL secretion in live swine. We observed that there is a CFTR-
dependent basal spontaneous ASL secretion from airway submucosal gland in the upper airway 
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of live wild type swine. The basal spontaneous ASL secretion seems to provide a basal amount 
of liquid in the surface of the airway, which is important for mucociliary clearance. Also, the 
constant release of liquid from airway submucosal glands results in the steady washout of 
antimicrobial factors from the glands and into the lumen of the airways (Dajani et al., 2005; 
Widdicombe and Wine, 2015). The presence of antimicrobial factors would also be an 
important part of airway defense mechanism. Since this basal spontaneous ASL secretion is 
CFTR-dependent, this process is significantly limited in CF airway. This basal glandular ASL 
secretion may be recovered by hypertonic saline nebulization treatment. Thus, in addition to 
increasing ASL hydration, hypertonic saline treatment increases antimicrobial factors and 
mucins in the airway. Thus, it would predispose the airway to fight infections. Other procedures 
that cause vagal stimulation of the airway, such as heavy exercise, may offer similar advantages.   
      
6.2.3 Impacts on the treatment of CF airway disease 
     As many experiments suggest, abnormal ASL in CF airways is the pathogenic event that 
triggers a cycle of infection and inflammation that can eventually lead to respiratory failure 
(Joris et al., 1993; Smith et al., 1996; Choi et al., 2009; Pezzulo et al., 2012; Widdicombe and 
Wine, 2015). My research further provides the evidence of failure of ASL secretion in response 
to inhaled bacteria in the CF airway, which reduces bacteria killing and impaired mucociliary 
clearance. The repeated cycles of infection and inflammation would finally result in airway 
remodeling, obstruction, and lung failure in the CF patients.  
     Thus, treatments that focus on improving bacteria clearing would benefit CF patients, 
and may avoid the progression of the lung disease to more severe stages.  
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6.3 Limitations of this study 
     Despite the novel findings of my research, there are also some limitations. 1) Using the 
synchrotron-based PCI method that we developed, the height of the ASL layer could only be 
measured using the agarose beads at the top and bottom of the trachea (Chapter 2 and 3). As a 
result, our method did not necessarily provide an overall detail about the height of the ASL 
layer covering the entire trachea, but rather a measurement just at the sites where the beads are 
located. 2) We used the agarose bead as a ‘measuring rod’ to measure the height of the ASL 
layer (Chapter 2 and 3). The beads on the airway resulted in slight deformation of trachea 
surface, which might stimulate the rapidly adapting pulmonary stretch receptors in the upper 
airway and trigger ASL scretion (Widdicombe, 2001). However, since we focus on the changes 
in the height of the ASL layer over time triggered by bacteria-laden and bacteria-free beads, 
both of wich would have the same mechanical effect on the receptors, the mechanical effect on 
the trachea should not affect our conclusions. 3) In our SIET experiments, in order to improve 
our signal-to-noise ratio of our measurements, we reduced Na+ and Cl- concentrations in the 
Krebs solution while we measured the Na+ and Cl- transports at different segements of airway 
submucosal gland (Chapter 5). The reduction of Na+ or Cl- ions in the bath might affect the 
electrochemical gradients driving ion transport, and thus the ion transport rate and direction. 
The absolute value of transport rate is, therefore, an artifact of the experimental conditions. 
However, the patterns of response to stimulation with forskolin and carbachol are informative. 
To interprete our results, we also use well established secretion assays to inform our 
conclusions. 
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6.4 Future directions and perspectives 
     There are several future experiments that can be done to enhance the understanding 
bacteria-airway submucosal gland interaction, to improve HTS treatment for CF patients, and 
to draw the full picture of airway submucosal gland function. 
     1) We have shown that inhaled bacteria stimulated ASL secretion from airway 
submucosal gland, but there is a link missing in the process. The question that remains is, what 
paracrine signal(s) is/are involved in the bacteria-triggered response? Evidence suggests that 
proinflammatory cytokines may be involved. ELISA and MultiPlex techniques can be used to 
test whether one or more paracrine signals are released from airway surface epithelia to 
stimulate the airway submucosal gland cells. Also, histology can be used to investigate whether 
other immune cells contribute to this fast-acting airway innate immune defense against inhaled 
bacteria. 
     2) We described that HTS stimulates airway sensory neurons and triggers epithelia ion 
transport, which produces ASL secretion. As a result, this is a possible target to modify the 
current HTS treatment approach to extend the effect of HTS, which would further help CF 
patients to improve their respiratory symptoms. Pharmacological agents that may modulate 
neuronal function, such as capsaicin, can be used to recruit airway sensory neurons during 
hypertonic saline treatment to manipulate the intensity and duration of the treatment on ASL 
secretion.  
     3) Measuring intraluminal pH changes at different segments of airway submucosal gland 
would be an interesting experiment. Since CFTR anion channel transports both Cl- and HCO3- 
ions, and the ASL pH seems to play important role in determining the ASL properties and 
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efficacy of the airway innate immune defence. As a result, each segment of airway submucosal 
gland might have different contributions to the pH change in ASL, and it would be interesting 
to know their function to better understand of submucosal gland function on CF 
pathophysiology.  
 
     Finally, the future for CF patients looks promising. Advances on the understanding of 
the lung disease pathogenesis, as well as the recent developments of CFTR correctors of 
trafficking to the membrane deficiency, as well as a potentiators, that increases the opening 
probability of CFTR, hold tremendous potential to improve the prognosis of CF patients. 
Recently, using high throughput screening of large compounds libraries, CF researchers have 
developed correctors and potentiators (e.g. lumacaftor and ivacaftor) that help CF patients with 
G551D mutation, and to a lesser extent some other mutations, to significantly improve the 
activation of CFTR and improve their health (Accurso et al., 2010). It is expected that new 
drugs may be discovered to help patients with other mutation. Furthermore, better 
understanding to CF pathogenesis will allow for the development of therapies to abrogate or 
slow the onset of CF lung disease. 
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